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Dimethyl heptalene-4,5-dicarboxylates3) undergo at temperatures below –50° 
with α-lithiated alkyl  phenyl sulfones preferentially a Michael addition reaction 
at C(3) leading to corresponding cis-configured 3,4-dihydroheptalene-4,5-
dicarboxylates (cf. Table 1, Scheme 3 and 4). The corresponding 1-furanone 
type pseudoesters of dimethyl heptalene-4,5-dicarboxylates (Scheme 5) react 
with ((phenylsulfonyl)methyl)lithium almost exclusively at C(1) of the furanone 
group (Scheme 6). In contrast to this expected behaviour, occurs the uptake 
of (1-(phenylsulfonyl)ethyl)lithium at C(5) of the 1-furanones as long as they 
carry a methyl group at C(12) (Scheme 6 and 7). The 1,4- as well as the 1,6-
addition products eliminate on treatment with MeONa/MeOH in THF 
benzenesulfinate, thus leading to 3- and 4-alkylated dimethyl heptalene-4,5-
dicarboxylates, respectively (Scheme 8 – 13). The stereochemistry of the 
addition reaction of the nucleophiles to the inherently chiral heptalenes is 
discussed in detail (cf. Scheme 14 – 19) on the basis of a number of X-ray 
                                                
1)  Part of the Ph.D. thesis of Z.A.M., University of Zurich, 2002.  
2) Part of the MS thesis of P.G., University of Zurich, 2000. 
  
3) The locants of heptalene itself are maintained throughout the whole 
work. See footnote 4 in [1] for reasoning.  
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crystal-structure determinations as well as by studies of the temperature-
dependence of the 1H-NMR spectra of the addition products.    
 
1. Introduction. – Substitution reactions at the 12π-electron annulene core of 
heptalenes under spontaneous re-establishment of the 12π-electron skeleton, 
as it is well known for aromatic substitution reactions due to the recovery of 
aromatization energy, are unknown. The situation changes on the level of 
transition-metal complexes of heptalenes. In this way, Vogel et al. [2] 
synthesized, for example, heptalene-1,6-dicarbaldehyde by Vilsmeier formy-
lation of the cis-configured bis(tricarbonyliron) complex of heptalene. This type 
of electrophilic substitution reaction can also be realized, however, with 
Fe(CO)3 complexes of open-chain hexa-1,3,5-trienes (see, e.g., [3]). We have 
recently realized an electrophilic acetoxylation reaction of a MeO substituted 
heptalene-4,5-dicarboxylate, taking advantage of a corresponding heptale-
none as a relay compound [1]. The principle is displayed in Scheme 1. It de-
monstrates the procedure that generally has to be followed when we 
undertake substitution reactions at C=C bonds in aliphatic or alicyclic 
surroundings, where we mostly have to deal with individual addition and 
elimination steps or, in rarer cases, the reverse steps, respectively. 
 
Scheme 1 
 
 
Here, we report on a new alkylation procedure at C(3) or C(2) of heptalene-
4,5-dicarboxylates and one of their pseudoester forms, respectively. It is 
based on the afore-mentioned two-step principle, using the Michael-addition 
reaction of α-lithiated alkyl phenyl sulfones in the first step and the based- 
catalyzed elimination reaction of benzenesulfinate in the second “re-estab-
lishment” step. 
 
2. Results and Discussion. – 2.1. Alkylation of Heptalene-4,5-dicarboxylates 
at C(3). We knew from our earlier alkylation experiments of dimethyl 
heptalene-4,5-dicarboxylates with lithiomethyl phenyl and other lithiomethyl 
sulfones that these nucleophiles did not react exclusively with the sterically 
 3 
less hindered methoxycarbonyl group at C(4), but also to a varying extent at 
C(3) of the heptalene skeleton in a Michael-type addition reaction [4][5]. We 
were interested therefore to find the optimal conditions for the Michael-addi-
tion pathway and the optimal base for the planned subsequent elimination 
reaction of the corresponding sulfinates (Scheme 2). 
 
Scheme 2 
 
Dimethyl heptalene-4,5-dicarboxylate (1) itself reacts with ((phenylsulfonyl)-
methyl)lithium in THF at –78° exclusively at C(3) and so do a number of other 
simply substituted heptalene-4,5-dicarboxylates, leading thus in good yields to 
the corresponding cis-configured 3-((phenylsulfonyl)methyl)-3,4-dihydrohep-
talene-4,5-dicarboxylates as an almost 1 : 1 mixture of epimers with respect to 
the axis (C(5a)–C(10a)) of chirality (Table 1).  
 
Table 1 
 
However, the reaction of 9 with ((phenylsulfonyl)methyl)lithium gave as a side-
product small amounts of the alkylation product of MeOOC–C(4) as the 
sterically less hindered ester group, a fact that we had observed already in our 
former experiments with heptalene-4,5-dicarboxylates with a higher number of 
peri-substituents [4]. A more detailed investigation with the heptalene-4,5-
dicarboxylates 11 and 14, derived from 1,4,8-trimethylazulene and guaiazu-
lene, respectively, showed that the ratio of Michael addition at C(3) and the 
alkylation reaction at MeOOC–C(4) is strongly dependent on the applied 
reaction temperature (Scheme 3). The observation that the ratio Michael 
adduct to alkylation product changes substantially in favor of the latter at –20° 
speaks for the fact that the Michael addition at C(3) is reversible whereas the 
alkylation at MeOOC–C(4) is irreversible due to the rapid elimination of 
methoxide and deprotonation of the formed (phenylsulfonyl)acetyl group at 
C(4). The electronic nature of the (sulfonyl)methyllithium nucleophile has no 
great influence on the said ratio as experiments with N,N-diphenylmethane-
sulfonamide and 4-(methylsulfonyl)morpholine demonstrate. 
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Scheme 3 
 
Much more effective in view of the ratio of Michael addition at C(3) versus 
alkylation at MeOOC–C(4) turned out to be the presence of an α-Me sub-
stituent in ((phenylsulfonyl)methyl)lithium as experiments with (1-(phenyl-
sulfonyl)ethyl)lithium showed (see Scheme 4 and later). The higher nucleo-
philicity and steric encumbrance of the α-branched ethyllithium reactant favor 
distinctly its 1,4-addition in comparison with the 1,2-addition. 
 
Scheme 4 
 
2.2. Alkylations of Heptalene Pseudoesters at C(5). As we have reported 
already in earlier publications, heptalene-4,5-dicarboxylates can be trans-
formed via their half-esters into the corresponding regioisomeric pseudoesters 
[6][7], which allow selective reactions at their carbonyl groups (Scheme 5) 
[5][8]. In the course of these investigations, we were quite astonished to find 
that the furan-1-one 25, derived from heptalenediester 14, reacted with 
((phenylsulfonyl)methyl)lithium in the expected manner whereas its reaction 
with (1-(phenylsulfonyl)ethyl)lithium led to a completely unexpected product, 
namely, as an X-ray crystal-structure determination (see later) revealed, to the 
1,6-addition product 27 (Scheme 6). Further experiments disclosed that a me-  
 
Scheme 5 
Scheme 6 
 
thyl group at C(12) of the heptaleno[1,2-c]furan-1-ones and at the α-position 
of the ((phenylsulfonyl)alkyl)lithium reactants are decisive for the formation of 
1,6-adducts, whereas the presence or absence of an Me group at C(6) has no 
significant influence on the addition of the alkyllithium nucleophile  at C(5) of 
the heptaleno[1,2-c]furan-1-ones (Scheme 7).  
 
Scheme 7 
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The crystal structure of the 1,6-adducts 30 and 31 was again determined by 
an X-ray diffraction analysis (see later). The reaction of furan-1-one 32 with 
(1-(phenylsulfonyl)ethyl)lithium gave mainly alkylation at C(1) resulting in the 
formation of 33, and only small amounts of furanone 34 were identified 
spectroscopically.  
 
Fig. 1 
 
The AM1 calculated structure of furan-1-one 25 clearly reveals the reason for 
its propensity to undergo a 1,6-addition reaction with (1-(phenylsulfonyl)-
ethyl)lithium (Fig. 1). The perspective view of (P)-25 with the dotted van der 
Waals surface of the O-atom of the carbonyl group and Me–C(12) plainly 
demonstrates that the re-face of the carbonyl group is perfectly shielded by 
Me–C(12) against a nucleophilic attack. On the other hand, the si-face of the 
carbonyl group cannot take up a nucleophile since the van der Waals surfaces 
of the O-atom of the carbonyl group and Me–C(12) are touching each other, 
so that there is no free space for the necessary bending mode of the carbonyl 
group when changing from sp2 to sp3 hybridisation on addition of a nucleo-
phile. Moreover, the torsion angles Θ (O=C(1)–C(12b)–C(3a)) and Θ (C(12b)–
C(3a)–C(4)–C(5)) amount to 178° and 25°, respectively, ideal for the uptake of 
a nucleophile at C(5), which exerts no influence on the packed spatial 
arrangement at the carbonyl group since the sp2 → sp3 bending mode takes 
place at C(5). In the case of furan-1-ones without an Me group at C(12) (e.g. 
32; see also [5]), the spatial interactions at the carbonyl group are strongly 
reduced, so that the 1,2-addition of a nucleophile at the carbonyl group is 
favored.  
 
2.3. Elimination Reactions with the 1,4- and 1,6-Adducts. After the failure of 
elimination reactions of the 1,4-adduct 15 with DBU (1,3-diazabicy-
clo[5.4.0]undecane) or LDA (lithium di-isopropylamide) as a base in THF 
according to Scheme 2, we found that MeONa in boiling MeOH/THF was the 
system of choice for the wanted removal of PhSO2–, followed by base-
catalyzed tautomerisation (Scheme 8). The formed heptalenedicarboxylate 
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was obtained as a thermal equilibrium mixture of 35 and its double bond 
shifted (DBS) isomer 35ʼ, which we had obtained already earlier with a 
number of other products by thermal reaction of 3-methylguaiazulene with 
dimethyl acetylenedicarboxylate in decalin at 200° (cf. [9]). Other leaving 
groups such as Ph2NSO2– (16% of 35/35ʼ) or O(CH2)4NSO2– (0% of 35/35ʼ) 
were less successful. The adduct 17 could also be reacted with LDA in THF, 
even though the yield of 35/35ʼ (6%) was low, and 19 gave no product at all 
under these conditions. Further elimination reactions, which led in moderate to 
good yields to some new alkylated heptalenedicarboxylates are compiled in 
Scheme 94). 
  
Scheme 8 
Scheme 9 
 
The (phenylsulfonyl)methyl or 1-(phenylsulfonyl)ethyl moiety at C(3) of the 
3,4-dihydroheptalene-4,5-dicarboxylates should principally allow the nucleo-
philic introduction of further alkyl groups at C(1) of the sulfonylalkyl 
substituents. However, the presence of MeOOC–C(4) may favor a nucleo-
philic alkylation at C(4). This is indeed the case. When 23 was deprotonated 
with NaH, followed by addition of MeI, the C(4)-methylated 3,4-
dihydroheptalene-4,5-dicarboxylate 41 was obtained almost quantitatively 
(Scheme 10)5). Its relative configuration was determined by an X-ray crystal-
structure analysis (see later). Treatment of 41 under the established 
elimination conditions led at least in a yield of 20% to the corresponding 3-
ethylidene-3,4-dihydroheptalenedicarboxylate 42 (Scheme 10). Its (3E)-
                                                
4) The standard elimination procedure applied on 21 did not lead to the 
formation of 3-ethylheptalenedicarboxylates 37/37ʼ (Scheme 9; R1, R3, 
R4 = H, R2 = Me). Due to a shortage of starting material, we could not 
repeat the elimination reaction of 21 with t-BuOK in THF (cf. 2 in 
Scheme 9). 
5)  We have not verified the possibility to trap the ester enolate of 23 by 
silylation, followed by a second deprotonation and then alkylation.   
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configuration follows from an anti-E2 elimination of PhSO2– of 416), which 
should deliver (P*,4R*)-42. However, (M*,4R*)-42 is, according to AM1 
calculations, at least by about 0.7 kcal·mol–1 energetically favored, therefore, 
we think that we obtained 42 in (M*,3E,4R*)-configuration as shown in 
Scheme 10.  
 
Scheme 10 
 
Quite astonishing was the result of the elimination reaction of 2 under our 
standard conditions with MeONa in MeOH/THF.  Instead of the expected hep-
talenedicarboxylate 36, which was found only in a small amount, we isolated 
its cyclic anhydride 43 in good yield (Scheme 11). Similarly, the heptalene 
sulfone 15 gave with t-BuOK or Et3COK in THF nearly equal amounts of the 
expected diesters 35/35ʼ and their common cyclic anhydride 44 (cf. [6] for 
DBS in cyclic anhydrides of heptalene-1,2- and -4,5-dicarboxylic acids). We 
suppose that, after deprotonation at C(4), the corresponding ester enolate A 
undergoes cyclization to B, which then loose methoxide to yield C, which 
represents the enol ether form of the cyclic anhydride of 15. The final step 
would then be the base-induced, formal elimination of PhSO2H to give the 
enol ether D. Treatment of the latter in the course of the working-up procedure 
with aqueous 2N HCl yields then the observed cyclic anhydride 44. Of course, 
we cannot exclude that the elimination already takes place at the stage of B 
and that the oxido-product of this reaction is present in the reaction mixture 
before working up. In other words, the decisive step in the discussed reaction 
sequence is the cyclization step, which might be dependent on the intra-
molecular flexibility of the 3,4-dihydroheptalene-4,5-dicarboxylates. A critical  
  
Scheme 11 
Scheme 12 
 
                                                
6) The (3E)-configuration of 41 is thermodynamically favored by about 2.5 
kcal·mol–1 with respect to the (3Z)-form of 41. 
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point may also be the elimination of PhSO2–, which should be dependent on 
the strength of the used base. Therefore, it is conceivable that the peri-
substituted 3-(sulfonylmethyl)-3,4-dihydroheptalene-4,5-dicarboxylates can be 
transformed to the corresponding heptalene-4,5-dicarboxylates with MeONa 
in MeOH/THF, whereas it needs the stronger bases t-BuOK or Et3COK in THF 
to observe in addition to diester formation also the formation of the correspon-
ding cyclic anhydride. 
 
It turned out that heating the 5-(1-(phenylsulfonyl)ethyl)-4,5-dihydrohepta-
leno[1,2-c]furans with MeONa/MeOH in THF was also successful for the for-
mation of the corresponding 2-ethylated heptalene-4,5-dicarboxylates by 
elimination of PhSO2H (Scheme 13). 
  
Scheme 13 
 
All new heptalenedicarboxylates were fully characterized spectroscopically 
and the structure of 45 was also determined by an X-ray diffraction analysis 
(see Exper. Part, Table 7). It is of interest to note that in the course of the 
elimination reaction of 31 epimerization at the axis of chirality of 31 and/or 47 
took place only to an extent of 10%. On standing at ambient temperature in 
CDCl3 solution, the 1 : 9 ratio of 47/47ʼ was slowly reversed. After two months, 
the ratio approached a value of almost 12 : 1 in favor of 47.  
 
2.4. Structural Characterization of the Michael Addition Products. 2.4.1. 3-
Alkylated 3,4-Dihydroheptalene-4,5-dicarboxylates. In our former reports on 
the reaction of higher alkylated heptalene-4,5-dicarboxylates with ((X-
sulfonyl)methyl)lithium, the relative configuration of the formed 3-alkylated 
heptalene-4,5-dicarboxylates had been of minor concern [4][8]. We assumed 
that these compounds possessed relative cis- and trans-configuration with 
respect to the spatial arrangements of the substituents (XSO2CH2, COOMe) at 
C(3)–C(4). This view was supported by an X-ray crystal-structure 
determination of one of the isomers of 19 (cf. Scheme 3)7), which revealed its 
                                                
7) See compound 6a in Scheme 3 of [4]. 
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relative cis-configuration, whereas the relative (M)-configuration at the axis of 
chirality (C(5a)–C(10a)) had been overlooked, since it was not in the focus of 
our interest at that time. On this basis, and without any further investigation, 
we assigned the trans-configuration to the second isomer of 198), found in 
solution, and which, together with its crystallized form, was only characterized 
by its 1H-NMR spectrum in C6D69).  
We were surprised when we found in this work that with the exception of the 
mixture of the two isomers of 10, all the simply substituted 3-alkylated 3,4-
dihydroheptalene-4,5-dicarboxylates, listed in Table 1, showed, as mixtures at 
ambient temperature, in their 1H-NMR spectra coalescence of almost all of the 
signals, and it needed temperatures as low as 223 K to get sharp signals of 
both isomers of the Michael adducts. Moreover, a temperature scan in steps 
of 10 K between 300 to 223 K revealed that at first most of the signals of both 
isomers became sharp, followed finally by the signals of H–C(3) and H–C(4) 
of the isomers. These observations excluded the existence of cis/trans pairs 
of isomers, but they were in full agreement with the presence of thermally 
converting epimers with respect to their axis of chirality. Fortunately, we 
obtained crystals of one isomer each of the 1-methyl- and 1,6-dimethyl-3,4-
dihydroheptalenedicarboxylate 4 and 10, respectively, which were suitable for 
an X-ray crystal-structure determination (Fig. 2 and 3). Both compounds 
showed a cis-arrangement of the substituents at C(3) and C(4), however, with 
opposite relative configuration at their axis of chirality (C(5a)–C(10a)). Thus, 
the crystals of 4 contained the pure (P*,3R*,4R*)-isomer and those of 10 the 
pure (P*,3S*,4S*)-form10).  
 
Fig. 2 
Fig. 3 
                                                
 
8) See compound 6b in Scheme 3 of [4]. 
 
9) See Table 10 in [4]. 
10) The latter, when dissolved at room temperature in C6D6, slowly equili-
brated to a 2 : 1 mixture with its (M*,3S*,4S*)-epimer. 
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Systematic 1H- and 13C-NMR analyses of all prepared dimethyl 3-(1-(X-
sulfonyl)alkyl)-3,4-dihydroheptalene-4,5-dicarboxlates (cf. Table 1, Scheme 3, 
4, and 10) revealed that all dicarboxylates, which carried no substituent at 
C(6) (see 2, 4, 8) appeared with relative (P*,3R*,4R*)-configuration, whereas 
those with a Me group at C(6) (6, 10, 12, 15, 17, 19, 23, 41) had the relative 
(P*,3S*,4S*)-configuration. The observation that all Michael-addition products 
of the heptalene-4,5-dicarboxylates exhibit relative cis-configuration of the 
substituents at C(3)–C(4) is in agreement with the fact that the protonation of 
the primarily formed C(4)-ester enolates takes place in a trans-relationship to 
the bulky (1-(X-sulfonyl)alkyl) group at C(3)11). 
 
Intramolecular proton transfer does not seem to play a role in the protonation 
step. This is evident by the fact that the alkylation experiment of the C(4)-ester 
enolate of 23 with MeI, which gave exclusively the C(4)-methylated product 41 
with retention of configuration at C(4) (Scheme 10) as revealed by its X-ray 
crystal-structure analysis (Fig. 4), and which showed the same (P*,3S*,4S*)-
configuration at the 3,4-dihydroheptalene core as the starting material 23 (see 
[5] for the X-ray structure of 23)12). However, the (R*)-configured 3-(1-
(phenylsulfonyl)ethyl) group of 23 underwent, obviously due to the basic 
conditions of the methylation reaction, complete epimerization to (S*)-config-
guration in 41. 
 
Fig. 4 
                                                
11) AM1 calculations of (P*)-4 and (P*)-10, which very well reproduced 
their crystal structures, showed that the ΔHf° values of their corres- 
ponding trans-forms, (P*,3R*,4S*)-4 and (P*,3S*,4R*)-10, respectively, 
are lying 2.1 and 2.3 Kcal⋅mol–1, respectively, higher in energy, i.e., the 
3,4-cis-configured 3,4-dihydroheptalenes are the thermodynamically 
favored forms.  
12) In this case, AM1 calculations showed the cis-methylation product to be 
3.3 Kcal⋅mol–1 less stable than the trans-product, (P*,1ʼS*,3S*,4R*)-41.  
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The global events of the formation of the Michael products are very simple 
(Scheme 14). Since we found only the cis-3,4-dihydroheptalene-4,5-dicarb-
oxylates, the two epimers of which represent, due to their labile axis of 
chirality, the thermodynamically controlled products. 
 
Scheme 14 
 
However, there are principally two ways by which the uptake of the 
nucleophile can occur. The simplest mode is shown in the scheme. It means 
that the axial attack of the nucleophile would take place only at one of the 
prochiral sites of C(3). In other words, the decisive step of the alkylation 
reaction happens with 100 % stereoselectivity. The other mode would be that 
the nucleophile attacks C(3) with a certain stereoselectivity at both of its 
prochiral sites (Scheme 15). 
 
Scheme 15 
 
To get more insight into these two modes, which do not alter the global 
stereochemical outcome, we performed a number of AM1 calculations. First of 
all, X-ray crystal-structure determinations as well as calculations show for 
heptalene-4,5-dicarboxylates an s-cis-conformation of the ester C=O group at 
C(4) in relation to the C(3)=C(4) bond with Θ of 20° and below, independent of 
the number of peri-substituents (Table 2).  
 
Table 2 
Table 3 
 
AM1 calculations with methanide as model nucleophile show that the axial 
cisoid ester-enolates, formed on the re path, are energetically favored by 2.3 – 
5.8 Kcal⋅mol–1, compared with those resulting from the si-path (Table 3). The 
reason for this difference can be seen in the almost perfect s-trans torsion 
angle at C(4)–C(5) of the (P*,R*)-products, which allows a much better 
delocalization of the negative charge of the ester-enolates already in the 
 12 
transition state. This torsion angle stays almost constant (around 145°) on the 
way to the (P*,S*)-ester enolates13). Therefore, we assume that only the re 
path and the respective si path are responsible for the uptake of a nucleophile 
at C(3) of the discussed (P)- and (M)-heptalenediesters.  
 
The crystal structures of (P*,3R*,4R*)-4 and (P*,3S*,4S*)-10 disclose the 
presence of principally a third element of chirality, namely that of the helical 
turn of the 3,4-substituted fragment C(2)–C(3)–C(4)–C(5) with (+)-sc torsion 
angles of 69.5(3)° and 67.9(2)°, respectively. The fragment is part of a seven-
membered ring in a boat-like conformation with C(4) in the bow position. AM1 
calculations of model Michael adducts of diesters 1, 3, 5, and 9 again with 
methanide as nucleophile indicate that a second conformation is possible, 
wherein the fragment possesses (–)-sc conformation and C(3) takes the bow 
position (Table 4). One recognizes that Me substituents at the heptalene core 
markedly influence the thermodynamic stability of the two diastereoisomers as 
well as the preferred conformation of their 3,4-dihydro ring. A Me group at 
C(6) shifts the relative configuration from (+)-sc-(P*,3R*,4R*) to (+)-sc-
(P*,3S*,4S*), just as observed in the crystal structures of 4 and 10. Moreover, 
one can see that the (+)-sc-(P*,3R*,4R*) forms are without exception by 3 –  
 
 Table 4 
 
4.8 Kcal⋅mol–1 more stable than their (–)-sc conformers. The situation is more 
complex for the (P*,3S*,4S*)-configured diastereoisomers. In the cases with 
no substituent or a Me group at C(1) the (–)-sc forms are energetically slightly 
favored. However, a Me substituent at C(6) (or C(1) and C(6)) makes the (+)-
sc conformations more stable. Taking all together, one can say that the in-
vestigated 3,4-dihydroheptalene-4,5-dicarboxylates contain two fixed ele-
                                                
13) See the X-ray structures of 5 and 48 with Θ(C(5a)=C(5)–C(4)–CO2Me) 
of 145.3(2)° and 144.6(3)°, respectively. [Note that in these crystal 
structures, the atoms have been numbered as C10a=C10-C9-C12.] 
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ments of chirality (centers at C(3) and C(4)) and two principally dynamic 
elements of chirality (axes at C(5a)–C(10a) and C(3)–C(4)). 
 
To learn more about the molecular dynamics of 3,4-dihydroheptalenes, we 
calculated the transition state energies of the (P),(M) and (+)-sc,(–)-sc 
conversion of 3,4-dihydroheptalene (Scheme 16) and of (P,3S,4S)-3,4-
dihydro-1,3,6-trimethylheptalene-4,5-dicarboxylic acid (Scheme 17), close to 
the structure of the Michael adduct 10 with the highest number of peri-substi-
tuents. The AM1 calculated data for 3,4-dihydroheptalene itself show its (+)-
sc-(P) form more stable than its diastereoisomeric (–)-sc form, and the data 
listed in Table 4 indicate that substituents in positions 1, 3, 4, 5, and 6 can 
enlarge this energy gap up to 4.8 Kcal⋅mol–1. The rotational barrier at the ring 
bond C(3)–C(4) is with 3.0 and 4.4 Kcal⋅mol–1 expectedly low and clearly 
below the transition state energy of 6.6 and 8.0 Kcal⋅mol–1, respectively, for 
the change of configuration of the dihydroheptalene skeleton. The rotational 
barrier of 2.4 and 4.1 Kcal⋅mol–1 at the C(3)–C(4) bond for the above 
mentioned analog of 10 does not change very much in contrast to the 
corresponding inversion barrier of the dihydroheptalene configuration, which 
amounts to 16.9 and 17.5 Kcal⋅mol–1, respectively, and are strongly depen-
dent on the number of peri-substituents as known from their parent 
heptalenes (cf. [16]). The calculated data are in perfect agreement with the 
observed rapid, respectively, slow (P*,3S*,4S*)  (M*,3S*,4S*) conversion of 
6 and 10 at ambient temperature in solution. Moreover, the observed mostly 
broad signals for H–C(3) and H–C(4) in the 1H-NMR spectra of the lower 
substituted 3,4-dihydroheptalene-4,5-dicarboxylates speaks for an active 
dynamic equilibrium of the (+)-sc and (–)-sc ring conformers at the 
temperature range used for the NMR measurements of the 3,4-
dihydroheptalene-4,5-dicarboxylates.  
 
Scheme 16 
Scheme 17 
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2.4.2. 5-Alkylated 3,3-Dimethoxy-4,5-dihydroheptaleno[1,2-c]furan-1(3H)-
ones. The structure and relative configuration of the 4,5-dihydroheptaleno[1,2-
c]furane-1-ones (P*)-27, (P*)-30, and (P*)-31 were determined by X-ray 
crystal-diffraction analyses (see Figs. 5 and 6 as well as Table 7). Whereas 
the two former structures possess the same relative configuration, has the 
latter (P*,1ʼS*,5R*)-configuration. (P*)-27, when dissolved in CDCl3 at ambient 
temperature, rapidly forms a 2 : 1 mixture with its (M*)-epimer (Scheme 6). 
The two other compounds showed no noticeable epimerization during the time 
of their NMR measurement in CDCl3 solution at normal temperature14).  
 
The different relative configuration at C(5) of the 1,6-adducts speaks for the 
change of the site of the uptake of the nucleophile by the heptalenofuran-1-
one as shown in Scheme 18.  Since all three compounds exhibit the same (+)-
sc conformation at the C(4)–C(5) bond with Θ(C(3a)–C(4)–C(5)–C(6)) of 
64.8(2)° ((P*)-27)15), 57.6(2)° ((P*)-30), and 63.0(2)° ((P*)-31), it was of 
interest for us to look for the reason of this site selectivity. Table 5 lists the 
AM1 calculated ΔHf° values of the dienolate intermediates that are formed 
with the model nucleophiles methanide and 2-propanide by axial attack on the 
re- and si-site of C(5). All relaxed intermediates show (+)-sc conformations 
with Θ(C(3a)=C(4)–C(5)–C(6)) in the range of 52 – 63° for the (P*,5S*)-forms 
and 42 – 49° for the (P*,5R*)-forms. The two intermediate dienolate structures  
 
 Scheme 18 
Table 5 
 
arising from 28 and methanide are reproduced in Fig. 7. From the axial re at-
tack results the (+)-sc conformation with the added Me group in a pseudo-
equatorial position, whereas the addition on the si site delivers the (+)-sc 
conformation with the Me group in pseudoaxial position. The (+)-sc-(P*,5S*)-
                                                
14) See later for the reason.  
15)  (P*)-27 appears in the crystals with two different rotational orientations 
of the isopropyl group with respect to the heptalene core.   
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dienolate intermediates with methanide as nucleophile are by ΔΔHf° 0.5 – 1.9 
Kcal⋅mol–1 more stable than their (+)-sc-(P*,5R*) counterparts, a situation, 
which changes with the α-branched 1-methylethanide (propan-2-ide) as 
nucleophile where only the (+)-sc-(P*,5S*)-form, derived from 30, is by 1.0 
Kcal⋅mol–1 more stable than the corresponding (5R*)-form, whereas it is the 
(+)-sc-(P*,5R*)-form in the other two cases, which is by 1.6 – 1.8 Kcal⋅mol–1 
more stable. Therefore, it is reasonable to assume that indeed increasing 
steric interaction in the transition state of the 1,6-addition of 1-
(phenylsulfonyl)ethanide to the furanones leads to a change of the site of the 
attack. 
 
Fig. 7 
 
Protonation at C(4) of the dienolate intermediates leads to the corresponding 
4,5-dihydroheptaleno[1,2-c]furan-1-ones, which can also be regarded as 
furano-anellated 3,4-dihydroheptalenes. The calculated ΔHf° of the (+)- and (–
)-sc forms of the model compounds are listed in Table 6. One clear answer is 
that the (+)-sc conformers are principally more stable than the (–)-sc forms in 
accordance with the X-ray crystal structures of all three heptaleno[1,2-c]furan-
1-ones. Moreover, α-alkyl branching of the substituent at C(5) is sterically 
slightly better accommodated by the (P*,5R*)-configured furan-1-ones. 
 
We chose 3,3-dihydroxy-5,6,8,11-tetramethyl-4,5-dihydroheptaleno[1,2-c]fu-
ran-1(3H)-one as a model for 27 to get more insight into the molecular 
dynamics of the furano-anellated 3,4-dihydroheptalenes (Scheme 19). The 
ΔHf° values, listed in Table 6, demonstrated already that the (+)-sc-(P*,5S*)-
forms are much more stable than their (–)-sc relatives. The same is observed 
in the present case, where this energy difference amounts to 5.4 Kcal⋅mol–1. 
The transition state for the mutual conversion of the two conformers is –115.5 
Kcal⋅mol–1 above the ground states. The ΔHf‡ values for the (P,M)-epime-
rization of the two conformers into the most stable (–)-sc-(M*,5S*)-form 
amount to 20.4 and 15.0 Kcal⋅mol–1 in excellent agreement with the obser-
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vation that (P*,5S*)-27 isomerizes reversibly already at room temperature in 
CDCl3 solution to (M*,5S*)-27. 
 
Scheme 19 
 
3. Final Remarks. – There are at least two open points left. The first one 
deals with the directing and decisive steps of the base catalyzed elimination of 
PhSO2– at the structurally complex dimethyl 3,4-dihydro-3-(phenylsulfonyl)-
heptalene-4,5-dicarboxylate and 3,3-dimethoxy-5-(1-(phenylsulfonyl)ethyl)-
4,5-dihydroheptaleno[1,2-c]furan-1-ones. 
  
Deprotonation and  methylation of diester 23 yields the C(4) methylated 
diester 41 (Scheme 10), which demonstrates that H–C(4) is, as expected, 
more acidic than H–C(3). Moreover, the base catalyzed transformation of 41 
into 42 indicates that the elimination of PhSO2– takes place as a concerted E2 
process with anti stereochemistry. However, what happens when C(4) carries 
an H-atom as in all the other cases? One possibility would be that 
deprotonation at C(4) does not hinder the base catalyzed concerted E2 
process  as discussed above, taking into account that the adjacent negative 
charge will favor an early transition state on the reaction coordinate of the E2 
process. However, the fact that we found in some cases, which we have not 
investigated in detail, beside the alkylated heptalenedicarboxylates also their 
corresponding anhydrides speaks for an “anchimeric” assistance of the 
elimination reaction by the neighbored methoxycarbonyl group as depicted in 
Scheme 12. 
The elimination reaction of the dihydrofuran-1-ones 27, 30, and 31 seems to 
follow an concerted E2 mechanism since we have not observed an unusual  
reaction behavior. Nevertheless, it is remarkable that the average yield of the 
elimination reaction is higher in comparison with that of the dihydroheptalene-
dicarboxylates, which speaks for an easier E2 process of the dihydrofuran-1-
ones. 
The second point touches the question whether the described alkylation 
process with (1-(phenylsulfonyl)alkyl)lithium as alkyl group carrier can also be 
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realized with normal α,β-unsaturated carbonyl system. First experiments show 
that (1-(phenylsulfonyl)alkyl)lithium reactants are indeed excellent Michael 
addends for α,β-unsaturated compounds such as chalcone or methyl cinna-
mate (Scheme 20) [17]. However, the formed products 50 need at least two 
chemical steps to re-establish unsaturation of the β-alkylated compounds 51 
by elimination of benzenesulfinate. 
 
Scheme 20 
 
 
We are thankful to our NMR laboratory for specific NMR measurements and 
to our MS laboratory for mass spectra. Financial support of this work by the 
Swiss National Science Foundation is gratefully acknowledged.   
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Experimental Part 
 
General.  See [4][5][8]. All heptalene-4,5-dicarboxylates were prepared according to 
our published  procedures, whereby the corresponding azulenes were heated at 125 – 
130° with three mol-equiv. of dimethyl acetylenedicarboxylate in toluene. 1-
Methylazulene gave under these conditions only 1-methylheptalene-4,5-dicarboxylate 
3 (m.p. 136.0° (Et2O)) in a yield of 25% (cf. [11]) and 4-methylazulene  led to the 
formation of a 3 : 1 mixture (total yield 35%) of 6-methylheptalene-4,5-dicarboxylate 
5 (m.p. 119.1 – 120.3° (Et2O); for X-ray data, see Table 7) and its 10-methyl analog 
48 (m.p. 136.9 – 137.2° (Et2O); for X-ray data, see Table 7) (cf. [11]). Finally, the 
1,6,10-trimethylheptalene-4,5-dicarboxylate 11 (golden yellow crystals, m.p. 139.5 – 
141.0° (Et2O)) was obtained in a yield of 35% from 1,4,8-trimethylazulene, which 
was prepared by established procedures from 4,8-dimethylazulene [14]. For the 
synthesis of the 3,3-dimethoxyheptaleno[1,2-c]furan-1-ones, see [6]. 
 
1. Formation of the Dimethyl 3-(1-(phenylsulfonyl)alkyl)-3,4-dihydroheptalene-
4,5-dicarboxylates. – 1.1. Standard Procedure. Under an atmosphere of argon and 
under stirring, methyl or ethyl phenyl sulfone (4.00 mmol) is dissolved in THF (8 
mL) and cooled to –10°. During 10 min commercial BuLi in hexane (2.5M; 1.80 mL, 
4.5 mmol) is added drop by drop, whereby the temp. is raising to –2°. After 10 min, a 
fine colorless precipitate is formed. After a further 30 min at 0°, the solution is cooled 
to –78° and a solution of the heptalene-4,5-dicarboxylate (1 mmol) in THF (5 mL) is 
added during 5 min. The progress of the reaction is followed by chromatography 
(TLC; silica gel, hexane/AcOEt). After consumption of all heptalenediester, the 
mixture is poured on ice, acidified with aq. 2N HCl, and extracted with AcOEt. After 
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washing of the extract with water and then with satur. aq. NaCl solution, the extract is 
dried over Na2SO4.  
 
1.1.1. Dimethyl (P*,3R*,4*R)- and (M*,3R*,4R*)-3-((Phenylsulfonyl)methyl)-3,4-
dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-2). A 3 : 2 mixture (0.293 g, 
69%) of (P*)- and (M*)-2 was obtained as yellow oil. Rf (hexane/AcOEt 2 : 1) 0.17. 
IR (KBr): 1733s (C=O, ester), 1306s/1148s (sulfone). EI-MS: 426 (15, M+), 366 (2, 
[M – MeOCO]),  286 (10), 285 (53, [M – (MeOCO + PhSO2)]+),  272 (14), 253 (44, 
[M – (MeOCO + PhSO2 + MeOH)]+),  252 (85, [M – (MeOCO + PhSO2H + MeOH)]), 
240 (8, [PhSO2CH=CHCOOMe]+), 226 (12), 225 (55), 221 (16), 213 (14), 212 (10), 
209 (11), 186 (54, [C10H7COOMe]+), 135 (100).  
 
NMR data of (P*)-216): 1H-NMR (500MHz, CDCl3): At 300 K, almost all 
corresponding signals of the two epimers showed coalescence; spectrum at 223 K 
(CHCl3 at 7.260; 60 % of the (P*)-form): 8.00 (d, Jo = 7.5, Ho of PhSO2); 7.71 
(superimp. signals of Hp of PhSO2 of both forms); 7.63 (superimp. signals of Hm of 
PhSO2 of both forms); 6.68 – 6.47 (superimp. signals of H–C(6 – 10) and of H–C(7 – 
10) of (M*)–2); 6.35 (dd, 3J(2,1) = 11.9, 3J(2,3) = 6.3, H–C(2)); 6.24 (d, 3J(1,2) = 
12.1, H–C(1)); 3.95 (dd, 2J(HS,HR) = 13.7, 3J(HS,3) = 1.8, HS–C(1’)); ca. 3.76 (br. s, 
H–C(4); partly covered by the s of MeOOC–C(5) of (M*)-2); 3.69 (s, MeOOC–C(5)); 
3.50 (s, MeOOC–C(4)); 3.36 – 3.32 (superimp. signals of H–C(3) of both forms); 
3.12 (t-like, Σ 2J(HR,HS) + 3J(HR,3) = 25.7, HR–C(1’)). 13C-NMR (125 MHz, CDCl3, 
223 K; CDCl3 at 77.00): 171.45 (MeOOC–C(4)); 167.08 (MeOOC–C(5)); 52.17, 
52.14 (MeOOC–C(4,5)).  
 
                                                
16) Atoms of the (1-(R-sulfonyl)alkyl) groups are primed.  
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NMR data of (M*)-2: 1H-NMR (500MHz, CDCl3; 40 % of the (M*)-form): 7.95 (d, Jo 
= 7.5, Ho of PhSO2); 7.71 (superimp. signals of Hp of PhSO2 of both forms); 7.63 
(superimp. signals of Hm of PhSO2 of both forms); 6.87 (d, 3J(6,7) = 11.4 H–C(6)); 
6.68 – 6.47 (superimp. signals of H–C(7 – 10) and of H–C(6 – 10) of (P*)-2); 6.09 
(dd, 3J(2,1) = 12.1, 3J(2,3) = 3.0, H–C(2)); 5.79 (d, 3J(1,2) = 12.1, H–C(1)); 4.56 (br. 
s, H–C(4)); 3.77 (s, MeOOC–C(5)); 3.62 (dd, 2J(HS,HR) = 14.6, 3J(HS,3) = 5.6, HS–
C(1’)); 3.39 (s, MeOOC–C(4)); 3.56 (dd, 2J(Hr,Hs) = 14.6, 3J(Hr,3) = 7.1, Hr–C(1’)); 
3.36 – 3.32 (superimp. signals of H–C(3) of both forms). 13C-NMR (125 MHz, 
CDCl3, 223 K; CDCl3 at 77.00): 172.08 (MeOOC–C(4)); 166.16 (MeOOC–C(5)); 
52.42, 52.27 (MeOOC–C(4,5)). 
 
1.1.2. Dimethyl (P*,1’R*,3S*,4*S)- and (M*,1’R*,3S*,4S*)-3-((1-Phenylsulfo-
nyl)ethyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-21). Heptalene-
diester 1 (1.00 g, 3.70 mmol) was reacted with ethyl phenyl sulfone (0.95g, 5.56 
mmol) in the usual manner. The product was extracted with Et2O and further purified 
by SC (SiO2, hexane/AcOEt 2 :1), which gave 1.10 g (67 %) of a dark brown oil. The 
NMR analysis showed that the oil consisted of (P*)- and (M*)-21 in a ratio of ca. 45 : 
55. No signals were identified that could be assigned to 22 (see Scheme 5). 
 
Data of (P*)- and (M*)-21: IR (KBr): 1733s and 1700s (C=O, ester), 1305s and 
1146s (sulfone). 1H-NMR (300 MHz, CDC13, 300 K; identified signals): 7.9 – 7.5 (H 
of PhSO2 of both forms); 6.85 (d, 3J(6,7) = 11.3, H–C(6) of (M*)-form); 6.65 – 6.30 
(superimp. signals of both forms); 6.05 (dd, 3J(2,1) = 12.2, 3J(2,3) = 2.7, H–C(2) of 
(P*)-form); 4.47 (br. s, H–C(4) of (M*)-form);  4.06 (q, 3J(1’,Me–C(1’) = 7.1, H–
C(1’) of (M*)-form); 3.70 and 3.37 (2s, MeOOC–C(4,5) of (M*)-form); ); 3.65 and 
3.43 (2s, MeOOC–C(4,5) of (P*)-form); 1.22 (d, 3J(Me–C(1’),1’) = 7.1, Me–C(1’) of 
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both forms). 13C-NMR (75 MHz, CDC13; identified signals)16): 171.69 (MeOOC–C(4) 
of (M*)-form); 171.00 (MeOOC–C(4) of (P*)-form); 167.11 (MeOOC–C(5) of (P*)-
form); 166.35 (MeOOC–C(5) of (M*)-form); 147.16 (C(5a) of (M*)-form); 145.73 
(C(5a) of (P*)-form); 63.87 (C(1’) of (M*)-form); 60.11 (C(1’) of (P*)-form); 13.99 
(Me–C(1’) of (P*)-form); 13.08 (Me–C(1’) of (M*)-form). CI-MS: 458.1 (37, [M + 
NH4]+), 441.1 (100, [M + l]+), 409.1 (43, [(M + 1) – CH3OH]+), 299.1 (67, [(M + 1) – 
PhSO2H)]+), 272.1 (15, [(M + l) – C6H5SO2CHMe]+), 187.0 (28 [C10H8COOMe]+). 
 
1.1.3. Dimethyl (P*,3R*,4*R)- and (M*,3R*,4R*)-1-Methyl-3-((phenylsulfonyl)-
methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-4). Heptalenediester 
3 (0.200 g, 0.70 mmol) gave after reaction and crystallization (hexane/AcOEt) 0.206 g 
(67%) colorless crystals of (P*)-4 (m.p. 157°) as shown by an X-ray crystal-structure 
determination (Fig. 2 and Table 7). In CDCl3 solution at ambient temp., a ca. 45 : 55 
mixture of (P*)- and (M*)-4 was formed within minutes and the corresponding 
signals of the epimers showed coalescence. Rf (hexane/AcOEt 2 : 1) 0.16.  
 
Data of (P*)-4: IR (KBr): 1712s (C=O, ester), 1334s and 1155s (sulfone). 1H-NMR 
(700 MHz, CDCl3, 270 K; 45% of the (P*)-form; CHCl3 at 7.276): 8.02 (d, Jo = 7.6, 
Ho of PhSO2); 7.702 (t, Hp of PhSO2); 7.63 (t, Jo = 7.6, Hm of PhSO2); 6.53 (dd, 
3J(9,10) ≈ 7, 3J(9,8) ≈ 11, H–C(9)); 6.52 (d, 3J(10,9) ≈ 6, H–C(10)); 6.46 (dd, 3J(7,8) = 
6.3, 3J(7,6) = 11.1, H–C(8)); 6.29 (d, 3J(2,3) = 5.3, H–C(2)); 3.96 (d, 2J(HS,HR) = 13.4, 
HS–C(1’)); 3.80 (br. s, partly covered by the s of MeOOC–C(5) of (M*)-4, H–C(4)); 
3.50 (s, MeOOC–C(5)); 3.43 (br. s with spike amid, H–C(3)); 3.37 (s, MeOOC–C(4)); 
3.07 (t-like, Σ 2J(HR,HS) + 3J(HR,3) = 26.5, HR–C(1’)); 1.94 (s, Me–C(1)). 13C-NMR 
(176 MHz, CDCl3, 270 K; CDCl3 at 77.02): 171.45 (MeOOC–C(4)); 166.57 
(MeOOC–C(5)); 148.71 (C(5a)); 139.27 (Cip of PhSO2); 133.71 (Cp of PhSO2);  
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132.50 (C(1)); 131.29 (C(10a)); 131.06 (C(6)); 130.15 (C(2)); 129.34 (Cm of PhSO2);  
129.10 (C(7)); 128.48 (C(7)); 128.03 (Co of PhSO2)); 125.81 (C(8)); 125.61 (C(9)); 
120.20 (C(5)); 57.99 (C(1’)); 51.93 (MeOOC–C(5)); 51.88 (MeOOC–C(4)); 44.56 
(C(4)); 34.10 (C(3)); 27.37 (Me–C(1)). EI-MS: 440 (6, M+), 299 (32, [M – (MeOCO 
+ PhSO2)]+), 267 (6), 239 (10), 201 (11), 200 (100, [MeC10H6COOMe]+). Anal. calc. 
for  C24H24O6S (440.48): C 65.44 , H 5.49, S 7.28; found: C 65.36, H 5.43, S 7.41. 
 
Data of (M*)-4: 1H-NMR (700 MHz, CDCl3, 270 K; 55% of the (M*)-form):  7.97 (d, 
Jo = 7.6, Ho of PhSO2); 7.698 (t, Hp of PhSO2); 7.61 (t, Jo = 7.7, Hm of PhSO2); 6.76 (d, 
3J(6,7) = 11.1, H–C(6)); 6.69 (dd, 3J(9,10) = 7.1, 3J(9,8) = 10.5, H–C(8)); 6.66 (d, 
3J(10,9) = 6.8, H–C(10)); 6.63 (dd, 3J(8,9) = 10.6, 3J(8,7) = 6.5, H–C(8)); 6.43 (dd, 
3J(7,8) = 6.5, 3J(7,6) = 10.8, H–C(7)); 5.64 (s, H–C(2)); 4.34 (br. s, H–C(4)); 3.79 (s, 
MeOOC–C(5)); 3.65 (dd, 2J(HS,HR) = 14.6, 3J(HS,3) = 5.5, HS–C(1’)); 3.55 (dd, 
2J(HR,HS) = 14.6, 3J(HR,3) = 6.8, HR –C(1’)); 3.37 (s, MeOOC–C(4)); 3.29 (br. s, H–
C(3)); 1.86 (s, Me–C(1)). 13C-NMR (176 MHz, CDCl3, 270 K; CDCl3 at 77.02): 
171.98 (MeOOC–C(4)); 165.83 (MeOOC–C(5)); 149.03 (C(5a)); 139.13 (Cip of 
PhSO2); 133.83 (Cp of PhSO2); 132.55 (C(1)); 132.32 (C(10a)); 130.56 (C(8)); 130.17 
(C(9)); 129.34 (Cm of PhSO2); 129.14 (C(2) and C(10)); 128.00 (Co of PhSO2)); 
125.86 (C((6)); 125.36 (C(7)); 122.67 (C(5)); 60.44 (C(1’)); 52.17 (MeOOC–C(5)); 
52.02 (MeOOC–C(4)); 45.80 (C(4)); 34.19 (C(3)); 26.83 (Me–C(1)).  
 
1.1.4. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-6-Methyl-3-((phenylsulfonyl)-
methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-6). The standard 
procedure gave after crystallization (hexane/AcOEt) colorless crystals of (P*)-6 
(0.295 g, 67%; m.p. 157°). In CDCl3 solution at ambient temp., a 3 : 1 ratio of (P*)- 
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and (M*)-6 was established within minutes. Over a longer period, the ratio 
approached a final value of 3 : 2. Rf (hexane/AcOEt 2 : 1) 0.14. 
 
Data of (P*)-6: IR (KBr): 1743s (C=O, ester), 1309s and 1132s (sulfone). 1H-NMR 
(500 MHz, CDCl3, 250 K; 75 % of the (P*)-form): 8.01 (dd-like, Jo ≈ 7.3, Jm ≈ 1.4, Ho 
of PhSO2); 7.71 (tt-like, Hp of PhSO2); 7.63 (t-like, Hm of PhSO2); 6.53 – 6.48 (5 line 
m, of H–C(8,9) and H–C(8) of (M*)-form); 6.40 (d, 3J(10,9) = 6.9, H–C(10)); 6.33 
(dd, 3J(2,1) = 11.7,  3J(2,3) = 6.4, H–C(2)); 6.29 – 6.27 (br., slightly structured signal, 
H–C(7) of both forms); 6.23 (d, 3J(1,2) = 11.7, H–C(1)); 4.03 (dd, 2J(HS,HR) = 14.1, 
3J(HS,3) = 1.9, HS–C(1’)); 3.91 (d, 3J(4,3) = 2.1, H–C(4)); 3.71 (s, MeOOC–C(5)); 
3.47 (s, MeOOC–C(4)); 3.36 – 3.32 (br., slightly structured signal, H–C(3)); 3.08 (dd, 
2J(HR,HS) = 14.0, 3J(HR,3) = 11.7, HR –C(1’)); 2.03 (d, 4J(Me–C(6),7) ≈ 0.8, Me–
C(6)). 13C-NMR (125 MHz, CDCl3, 250 K, 75 % of (P*)-6; CDCl3 at 77.00;): 171.00 
MeOOC–C(4)); 168.16 (MeOOC–C(5)); 149.32 (C(5a)); 138.62 (Cip of PhSO2);  
133.83 (Cp of PhSO2); 133.55 (C(2)); 131.14 (C(6)); 129.95 (C(8)); 129.88 (C(10)); 
129.23 (Cm of PhSO2); 128.70 (C(10a)); 128.11 (C(1)); 128.07 (Co of PhSO2); 127.69 
(C(9)); 124.26 (C(7)); 122.48 (C(5)); 58.57 (C(1’)); 52.40 (MeOOC–C(5)); 52.06 
(MeOOC–C(4)); 46.09 (C(4)); 31.80 (C(3)); 24.88 (Me–C(6)). EI-MS: 440 (51, M+), 
300 (8), 299 (44, [M – (MeOCO + PhSO2)]+), 283 (8), 240 (6, 
[PhSO2CH=CHCOOMe]+), 239 (26), 209 (10), 208 (10), 207 (31), 201 (13), 200 
(100, [MeC10H6COOMe]+). Anal. calc. for C24H24O6S (440.48): C 65.44, H 5.49, S 
7.28; found: 65.38, H 5.42, S 7.35. 
 
Data of (M*)-6: 1H-NMR (500MHz, CDCl3, 250 K; 25% of the (M*)-form): 7.98 (dd-
like, Jo ≈ 7.3, Jm ≈ 1.4, Ho of PhSO2); 7.69 (tt-like, Hp of PhSO2); 7.61 (t-like, Hm of 
PhSO2); 6.50 (signals of H–C(8), mostly covered by those of H–C(8,9) of (P*)-6); 
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6.39 (dd, 3J(9,8) = 11.3, 3J(9,10) = 6.9, H–C(9)); 6.31 (d, H–C(10), partly covered by 
the signals of H–C(2) of (P*)-6); 6.29 – 6.27 (br., slightly structured signal, H–C(7) 
of both forms); 6.10 (dd, 3J(2,1) = 11.9, 3J(2,3) = 3.1, H–C(2)); 5.83 (dt-like, 3J(1,2) = 
11.9, H–C(1)); 4.35 (d-like, 3J(4,3) ≈ 1.2, H–C(4)); 3.80 (s, MeOOC–C(5)); 3.475 (br. 
signal, mostly covered by the signal of MeOOC–C(4) of (P*)-6, H–C(3)); 3.58 and 
3.57 (ABX, 2JAB = 14.4, 3JAX = 4.3, 3JBX = 8.5, HS- and HR–C(1’));  3.40 (s, MeOOC–
C(4)); 2.09 (br. s, Me–C(6)). 13C-NMR (125 MHz, CDCl3, 250 K, 25 % of (M*)-6; 
CDCl3 at 77.00;): 171.87 MeOOC–C(4)); 166.42 (MeOOC–C(5)); 151.21 (C(5a)); 
139.06 (Cip of PhSO2);  133.96 (Cp of PhSO2); 133.52 (C(1)); 132.13 (C(6)); 130.54 
(C(8)); 129.38 (Cm of PhSO2); 129.54 (C(10)); 128.59 (C(10a)); 127.89 (Co of 
PhSO2); 126.47 (C(9)); 125.87 (C(2)); 123.82 (C(5)); 123.00 (C(7)); 58.57 (C(1’)); 
52.40 (MeOOC–C(5)); 52.06 (MeOOC–C(4)); 46.09 (C(4)); 31.80 (C(3)); 24.88 (Me–
C(6)). 
 
1.1.5. Dimethyl (P*,3R*,4*R)- and (M*,3R*,4R*)-8-Methyl-3-((phenylsulfonyl)-
methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-8). Heptalenediester 
7 (0.200 g, 0.70 mmol) was reacted with methyl phenyl sulfone (0.440 g, 2.81 mmol) 
according to the standard procedure to give a ca. 3 : 2 mixture of (P*)- and (M*)-8 as 
a yellow oil. Rf (AcOEt/hexane 1 : 2) 0.18. IR (KBr): 1730s (C=O, ester), 
1308s/1150s (sulfone). 
 
NMR data of (P*)-8: 1H-NMR (500 MHz, CDCl3): At 300 K, coalescence of the 
corresponding signals of (P*)- and (M*)-8 was observed; spectrum at 223 K (CHCl3 
at 7.260; 60% of the (P*)-form): 7.98 (d, Jo = 7.5, Ho of PhSO2); 7.69 (superimp. 
signals of Hp of PhSO2 of both forms); 7.60 (superimp. signals of Hm of PhSO2 of both 
forms); 6.52 (d, 3J(6,7) = 11.7, H–C(6)); 6.49 (d, 3J(9,10) = 7.7, H–C(9)); 6.40 (d, 
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3J(10,9) = 7.6, H–C(10)); 6.29 (d, 3J(7,6) = 11.4, H–C(7)); 6.25 (dd, 3J(2,1) = 12.0, 
H–C(2)); 6.19 (d, 3J(1,2) = 12.1, H–C(1)); 3.93 (dd, 2J(HS,HR) = 13.7, 3J(HS,3) = 1.9, 
HS–C(1’)); 3.75 (br. s, H–C(4)); 3.67 (s, MeOOC–C(5)); 3.49 (s, MeOOC–C(4)); 3.34 
– 3.28 (superimp. signals of H–C(3) of both epimers); 3.11 (t-like, Σ 2J(HR,HS) + 
3J(HR,3) = 25.9, HR–C(1’)); 2.08 (Me–C(8)). 13C-NMR (125 MHz, CDCl3, 223 K; 
CDCl3 at 77.00; assigned signals): 171.52 (MeOOC–C(4)); 167.06 (MeOOC–C(5)); 
147.91 (C(5a)); 141.55 (C(8)); 138.16 (Cip of PhSO2); 119.15 (C(5)); 58.39 (C(1’)); 
52.09 (MeOOC–C(5)); 52.02 (MeOOC–C(4)); 46.32 (C(4)); 31.71 (C(3)); 24.75 (Me–
C(8)). 
 
NMR data of (M*)-8: 1H-NMR (500 MHz, CDCl3, 223 K; 40% of the (M*)-form): 
7.93 (d, Jo = 7.5, Ho of PhSO2); 7.69 (superimp. signals of Hp of PhSO2 of both 
forms); 7.60 (superimp. signals of Hm of PhSO2 of both forms); 6.83 (d, 3J(6,7) = 11.9, 
H–C(6)); 6.40 (d, 3J(9,10) = 7.7, H–C(6)); 6.34 (d, 3J(10,9) ≈ 7.6, H–C(10)); 6.25 (d, 
3J(7,6) = 11.4, H–C(6)); 6.09 (dd, 3J(2,1) = 12.2, 3J(2,3) = 2.8, H–C(2)); 5.70 (d, 
3J(1,2) = 12.1, H–C(1)); 4.56 (br. s, H–C(4)); 3.75 (s, MeOOC–C(5)); 3.62 (dd, 
2J(HS,HR) = 14.7, 3J(HS,3) = 5.7, HS–C(1’)); 3.53 (dd, 2J(HR,HS) = 14.7, 3J(HR,3) = 7.2, 
HR–C(1’); 3.40 (s, MeOOC–C(4)); 3.34 – 3.28 (superimp. signals of H–C(3) of both 
epimers); 2.07 (Me–C((8)). 13C-NMR (125 MHz, CDCl3, 223 K; assigned signals): 
172.06 (MeOOC–C(4)); 166.22 (MeOOC–C(5)); 147.65 (C(5a)); 141.80 (C(8)); 
138.20 (Cip of PhSO2); 121.70 (C(5)); 60.50 (C(1’)); 52.27 (MeOOC–C(5)); 52.20 
(MeOOC–C(4)); 47.54 (C(4)); 32.38 (C(3)); 24.69 (Me–C(8)).  
 
1.1.6. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-1,6-Dimethyl-3-((phenylsulfonyl)-
methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-10). The reaction of 
heptalenediester 9 with methyl phenyl sulfone under standard conditions delivered 
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after chromatography orange colored crystals of methyl 1,6-dimethyl-4-((phenylsul-
famoyl)acetyl)heptalene-5-carboxylate (0.011 g, 2.6%) and colorless crystals of (P*)-
10 (0.280 g, 62%). 
 
Data of (P*)-10: M.p. 163 – 164° (AcOEt/hexane). Rf (AcOEt/hexane 1 : 2) 0.13. On 
standing at r.t. in C6D6 solution, (P*)-10 formed a 2 : 1 mixture of (P*)- and (M*)-10. 
1H-NMR (600 MHz, C6D6, 300 K, 67% of (P*)-10; C6D5H at 7.160): 8.04 (d with f.s., 
Jo ≈ 7.3, Ho of PhSO2); 6.97 – 6.93 (superimp. signals of Hm of PhSO2 with those of 
Hm and Hp of (M*)-10); 6.91 (t with f.s., Jo ≈ 7.6, Hp of PhSO2); 6.61 (d with f.s., 
3J(7,8) = 5.9, H–C(7)); 6.25 – 6.23 (superimp. signals of H–C(8,9) with one of (M*)-
10); 6.15 – 6.12 (superimp. signal of H–C(10) with two of (M*)-10); 5.99 (dd-like, 
3J(2,3) = 3.4, 4J(2,Me–C(1)) = 1.4, H–C(2)); 4.78 (dd, 2J(HS,HR) = 14.0, 3J(HS,3) = 
1.9, HS–C(1’)); 3.72 (d, 3J(4,3) = 2.4, H–C(4)); 3.68 – 3.61 (superimp. signals of H–
C(3) of both epimers); 3.36 (dd, 2J(HR,HS) = 14.0, 3J(HR,3) = 11.4, HR–C(1’)); 3.22 (s, 
MeOOC–C(5)); 3.09 (s, MeOOC-C(4)); 1.76 (d-like, 4J(Me–C(1),2) ≈ 1, Me–C(1)); 
1.71 (s, Me–C(6)). EI-MS: 454 (22, M+), 315 (5), 281 (7), 253 (5), 249 (4), 221 (8), 
215 (14), 214 (100, [Me2C10H5COOMe]+). Anal. calc. for C25H26O6S (454.51): C 
66.06, H 5.76, S 7.05; found: C 65.90, H 5.73, S 7.19. 
The structure of (P*)-10 was finally established by an X-ray crystal-structure deter-
mination (see Table 7 and Fig. 3). 
 
Data of (M*)-10: 1H-NMR (600 MHz, C6D6, 300 K, 33% of (M*)-10): 7.83 (d with 
f.s., Jo ≈ 8, Ho of PhSO2); 6.97 – 6.93 (superimp. signals of Hm and Hp of PhSO2 with 
those of Hm of (M*)-10); 6.91 (t with f.s., Jo ≈ 7.6, Hp of PhSO2); 6.61 (d with f.s., 
3J(7,8) = 5.9, H–C(7)); 6.25 – 6.23 (superimp. signals of H–C(10) with those of two H 
of (P*)-10); 6.15 – 6.12 (superimp. signals of H–C(8,9) with one H of (P*)-10); 6.04 
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(d, 3J(7,8) = 6.2, H–C(7)); 5.64 (s with f.s., H–C(2));  4.63 (d with f.s., 3J(4,3) = 3.1, 
H–C(4)); 3.75 (dd, 2J(HS,HR) = 14.3, 3J(HS,3) = 6.2, HS–C(1’)); 3.68 – 3.61 (superimp. 
signals of H–C(3) of both epimers); 3.51 (dd, 2J(HR,HS) = 14.3, 3J(HR,3) = 6.5, HR–
C(1’)); 3.35 (s, MeOOC–C(5)); 3.13 (s, MeOOC-C(4)); 2.00 (s, Me–C(6)); 1.67 (dd, 
4J(Me–C(1),2) = 1.4, 5J(Me–C(1),10) = 2.2, Me–C(1)). 
 
Data of methyl 1,6-dimethyl-4-((phenylsulfamoyl)acetyl)heptalene-5-carboxylate: 
M.p. 216.7 – 217.1° (CH2Cl2/hexane). Rf (AcOEt/hexane 1 : 2) 0.07. 1H-NMR (300 
MHz, CDCl3): 7.89 – 7.86 (Ho of PhSO2); 7.66 – 7.50 (Hp and Hm of PhSO2); 7.33 (d, 
3J(3,2) = 5.6, H–C(3)); 6.48 (signals of H–C(8,9); 6.24 (dd-like, 3J(2,3) = 6.3, 
4J(2,Me–C(1)) = 1.4, H–C(2)); 6.19 (signals of H–C(7)); 5.94 (signals of H–C(10)); 
4.48 and 4.44 (AB, JAB = 14.1, PhSO2CH2); 3.59 (s, MeOOC–C(5)); 2.09 and 2.05 
(2s, Me–C(1,6)). EI-MS: 422 (22, M+), 313 (9), 281 (51, [M – PhSO2]+), 249 (39, [M – 
(PhSO2 +    MeOH)]+), 239 (11), 221 (19, [M – (PhSO2 + MeOH + CO)]+), 214 (34), 
179 (48), 156 (100, [Me2C10H6]+), 152 (20), 77 (20, Ph). 
 
1.1.7. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-9-Isopropyl-1,6-dimethyl-3-((phe-
nylsulfonyl)methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-15) and 
Methyl 9-Isopropyl-1,6-dimethyl-4-((phenylsulfamoyl)acetyl)heptalene-5-carboxylate 
(16) [5]. We repeated the formerly described reaction with methyl phenyl sulfone 
(1.02 g, 6.50 mmol) and heptalenediester 14 (1.00 g, 2.94 mmol) according to the 
above given standard procedure. Workup and chromatography (silica gel, 
hexane/AcOEt 3 : 1) gave after crystallization from AcOEt/hexane 2 : 1 colorless 
crystals of (P*)-15 (0.470 g, 35%) and orange colored crystals of 16 (0.306 g, 24%). 
At ambient temperature, in CDCl3 solution, (P*)-15 epimerized rapidly to a 3 : 1 
mixture with (M*)-15. 
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Data of (P*)-15: See [5]. 1H-NMR (300 MHz, CDCl3, 300 K, in the presence of 25% 
of its epimer; CHCl3 at 7.260): 8.02 – 7.97 (Ho of PhSO2 of both epimers); 7.69 – 7.65 
(Hp of PhSO2 of both epimers); 7.64 – 7.55 (Hm of PhSO2 of both epimers); 6.38 (s, 
H–C(10)); 6.28 (d, 3J(8,7) = 6.6, H–C(8)); 6.20 (dd, 3J(2,3) = 5.8, 4J(2,Me–C(1)) = 
1.0, H–C(2)); 6.15 (dd, 3J(7,8) = 6.5, 4J(7,Me–C(6)) = 1.2, H–C(7)); 4.01 (dd, 
2J(HS,HR) = 14.1, 3J(HS,3) = 1.9, HS–C(1’)); 3.88 (d, 3J(4,3) = 2.5, H–C(4)); 3.68 (s, 
MeOOC–C(5)); 3.46 (s, MeOOC–C(4)); ca. 3.43 (br. s, mostly covered by ester 
signals of both epimers, H–C(3)); 3.04 (dd, 2J(HR,HS) = 14.1, 3J(HR,3) = 11.4, HR–
C(1’)); 2.55 (sept, Me2CH–C(9)); 1.98 (s, Me–C(6)); 1.90 (s, Me–C(1)); 1.13/1.11 
(2d, superimp. to t, Jvic = 6.8, Me2CH–C(9)). 13C-NMR (75 MHz, CDCl3, 300 K; 
assigned signals): 170.98 (MeOOC–C(4)); 167.43 (MeOOC–C(5)); 151.52 (C(5a)); 
146.88 (C(9)); 139.83 (Cip of PhSO2); 58.41 (C(1’)); 51.84 (MeOOC–C(5)); 51.64 
(MeOOC–C(4)); 44.77 (C(4)); 35.83 (Me2CH–C(9)); 34.13 (C(3)); 26.10 (Me-C(1)); 
23.45/22.41 (Me2CH–C(9)); 23.28 (Me–C(6)). The full analysis of the 1H-NMR 
shows that the crystals contain the (P*,3S*,4S*)-epimer.  
 
Data of (M*)-15: 1H-NMR (300 MHz, CDCl3, 300 K, in the presence of 75% of its 
epimer; recognizable signals): 6.31 (s, H–C(10)); 6.30 – 6.15 (H–C(8) and H–C(7); 
signals covered by those of the epimer); 5.62 (br. s, H–C(2)); 4.24 (dd, J = 3.2 and 
1.1, H–C(4)); 2.48 (sept, Me2CH–C(9)); 2.00 (s, Me–C(6)); 1.86 (dd, J = 2.2 and 1.4, 
Me–C(1)); 1.10/1.09 (2d, superimp. to t, Jvic = 6.8, Me2CH–C(9)). 
 
Data of 16: Identical with those reported in [5]. 
 
1.1.8. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-1,6,10-Trimethyl-3-((phenylsul-
fonyl)methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-12)) and 
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Methyl 1,6,10-Trimethyl-4-((phenylsulfamoyl)acetyl)heptalene-5-carboxylate (13). 
Heptalenediester 11 (1.00 g, 3.21 mmol) was reacted with methyl phenyl sulfone 
following the standard conditions. Chromatography (silica gel, hexane/AcOEt 3 : 1) 
gave crude (P*)/(M*)-12 as a colorless oil (0.80 g, 63%) and 13, after crystallization 
from AcOEt/hexane 2 :1, in golden yellow needles (0.445 g, 37%). 
 
Data of (P*)/(M*)-12: Mixture of the two epimers in a ratio of 55 : 45. IR (film): 
1731s and 1700s (C=O, ester), 1307s and 1152s (sulfone). 13C-NMR (75 MHz, 
CDCl3, 300 K; identified signals, first value for (P*)-12, second for (M*)-12): 
171.80/171.57 (MeOOC–C(4)); 166.84/165.57 (MeOOC–C(5)); 156.94/155.31 
(C(5a)); 139.78/139.31 (Cip of PhSO2); 59.74/58.58 (C(1’)); 52.03/51.88 (MeOOC–
C(5)); 51.30/51.22 (MeOOC–C(4)); 44.73/44.37 (C(4)); 34.50/33.29 (C(3)). 
 
Data of 13: M.p. 171 – 172°. 1H-NMR (300 MHz, CDCl3, 300 K; CHCl3 at 7.260): 
7.87 (d with f.s., Ho of PhSO2); 7.62 (tt-like, Hp of PhSO2); 7.51 (t, Hm of PhSO2); 7.35 
(dd-like, 3J(3,2) = 5.9, 5J(3, Me–C(1)) = 0.9, H–C(2)); 6.42 (dd, 3J(8,9) = 11.1, 3J(8,7) 
= 5.6, H–C(8)); 6.33 (d, 3J(9,8) = 11.1, H–C(9)); 6.32 (dd-like, 3J(2,3) = 5.9, H–C(2)); 
6.13 (d, 3J(7,8) = 5.8, H–C(7)); 4.44 (s, H2C(1’)); 3.57 (s, MeOOC–C(5)); 2.03 (t-like, 
Me–C(6)); 1.97 (t-like, Me–C(1)); 1.78 (Me–C(1)). EI-MS: 496 (98, M+), 295 (40, [M 
– PhSO2]+), 263 (36, [M – (PhSO2 + MeOH)]+), 228 (14, [M – 
PhSO2CH2C(O)C≡CH]+), 170 (100, [Me3C10H5]+).  
 
1.1.9. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-9-Isopropyl-1,6-dimethyl-3-((mor-
pholinosulfonyl)methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and (M*)-19) 
[4]. We used the material prepared in 1996. According to our present analysis, 6a in 
[4] represents the (P*)-epimer as shown by its 1H-NMR (Table 10 in [4]) and its X-
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ray crystal-structure determination [4]. In turn, 6b in [4] is the corresponding (M*)-
form.  
 
1.1.10. Dimethyl (P*,3S*,4S*)- and (M*,3S*,4S*)-9-Isopropyl-1,6-dimethyl-3-((N,N-
diphenylaminosulfonyl)methyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)- and 
(M*)-17)) and Methyl 9-Isopropyl-1,6-dimethyl-4-((N,N-diphenylaminosulfamoyl)-
methyl)heptalene-5-carboxylate (18). The standard procedure with N,N-diphenyl 
methanesulfonamide (0.740 g, 3.00 mmol) [14] and heptalendiester 14 (0.465 g, 1.36 
mmol) gave after workup and chromatography (silica gel, hexane/AcOEt 3 : 1) a 3 :1 
mixture of (P*)- and (M*)-17 (0.585 g, 36%) as a yellow-brown oil and 18 (0.186 g, 
12%) as a dark brown oil. Both oils were not purified further. 
 
Data of (P*)-17: Thermal equilibrium mixture of 75% of (P*)-17 and 25% of (M*)-
17. IR (film): 1732s and 1712s (C=O, ester); 1347s and 1157s (sulfonamide). CI-MS: 
605.4 (22, [M + NH4]+), 588.4 (100, [M + 1]+), 556.4 (39, [(M + 1) – MeOH]+), 419.2 
(24, [(M + 1) – Ph2N]+), 355.3 (54, [(M + 1) – Ph2NSO2]+), 256.2 (11, 
[iPrMe2C10H4COOMe]+).   
1H-NMR (300 MHz, CDCl3, 300 K; in the presence of 25% of the (M*)-epimer): 7.55 
– 7.20 (arom. H of both epimers); 6.38 (s, H–C(10)); 6.28 (d, 3J(8,7) = 5.9, H–C(8)); 
6.14 (dd-like, 3J(7,8) = 6.6, 4J(7,Me–C(6)) = 1.4, H–C(7)); 6.11 (dd-like, 3J(2,3) = 5.9, 
4J(2,Me–C(1)) = 1.0, H–C(2)); 4.31 (dd, 2J(HS,HR) = 14.0, 3J(HS,3) = 2.0, HS–C(1’)); 
3.98 (d, 3J(4,3) = 2.4, H–C(4)); 3.72 (dd, partly covered by ester signals, 2J(HR,HS) = 
14.0, 3J(HR,3) ≈ 8, HR–C(3)); 3.67 (s, MeOOC–C(5)); 3.58 (s, MeOOC–C(4)); 3.42 
(br. s, H–C(3)); 2.54 (sept, Me2CH–C(9)); 1.90 (s, Me–C(1)); 1.85 (t-like, Σ (4J(Me–
C(6),7) + 5J(Me–C(6),8)) = 2.4, Me–C(6)); 1.13 and 1.11 (2d, Jvic = 6.9, Me2CH–
C(9)). 13C-NMR (75 MHz, CDCl3, 300 K; in the presence of 25% of the (M*)-epimer; 
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assigned signals): 171.15 (MeOOC–C(4)); 167.12 (MeOOC–C(5)); 151.83 (C(5a)); 
146.72 (C(9)); 141.10 (Cip of Ph); 123.96 (C(8)); 123.10 (C(7)); 120.79 (C(5)); 55.99 
(C(1’)); 51.71 (MeOOC–C(4,5)); 44.80 C(4)); 35.70 (Me2CH–C(9)); 34.62 (C(3)); 
25.95 (Me–C(1)); 23.14 (Me2CH–C(9)); 22.33 (Me–C(6)). 
 
Data of (M*)-17: 1H-NMR (300 MHz, CDCl3, 300 K; in the presence of ca. 75% of 
the (P*)-epimer; identified signals): 6.32 (H–C(10)); 6.30 – 6.09 (H–C(8) and H–
C(7); covered by the signals of the (P*)-17); 5.76 (br. s, H–C(2)); 3.76 (s, MeOOC–
C(5)); 3.42 (s, MeOOC–C(4)); 2.48 (sept, Me2CH–C(9)); 2.02 (Me–C(6)); 1.87 (t-
like, Σ 4J(Me–C(1),2) + 5J(Me–C(1),10) = 2.2, Me–C(1)); 1.11 and 1.09 (2d, Jvic = 
6.9, Me2CH–C(9)). 13C-NMR (75 MHz, CDCl3, 300 K; in the presence of ca. 75% of   
(P*)-17; assigned signals): 171.33 (MeOOC–C(4)); 166.29 (MeOOC–C(5)); 151.94 
(C(5a)); 145.91 (C(9)); 141.52 (Cip of PhSO2); 124.43 (C(8)); 122.50 (C(7)); 120.00 
(C(5)); 57.36 (C(1’)); 51.89 (MeOOC–C(4,5)); 46.25 (C(4)); 35.94 (Me2CH–C(9)); 
35.40 (C(3)); 25.69 (Me–C(1)); Me2CH–C(9)); 22.62 (Me–C(6)). 
 
Data of 18: 1H-NMR (300 MHz, CDCl3; significant signals only): 6.3 – 6.1 (H–
C(2,3,7,8)); 5.85 (s, H–C(10)); 4.50 and 4.44 (AB, JAB = 13.9, HAHB–C(2’)); 2.45 
(sept, Me2CH–C(9)); 2.07 (d-like, 4J(Me–C(1),2) = 1.1, Me–C(1)); 1.06 and 1.01 (2d, 
Jvic = 6.9, Me2CH–C(9)). 13C-NMR (75 MHz, CDCl3, 300 K): 188.45 (O=C–C(4)); 
167.64 (MeOOC–C(5)). 
 
1.1.11. Dimethyl (P*, 3S*,4S*)-9-Isopropyl-1,6-dimethyl-3-((R*)1-(phenylsulfonyl)-
ethyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)-23) and Methyl (P*)-7-Iso-
propyl-1,6-dimethyl-4-((S*)-2-(phenylsulfonyl)propionyl)heptalene-5-carboxylate 
(24). See [5] for the X-ray crystal structure of (P*)-23. The 1H- and 13C-NMR spectra 
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of (P*)-23 were again measured and all atom positions fully assigned. Some had to be 
corrected with respect to those reported in [5]. 1H-NMR (600 MHz, CDCl3, 300 K; 
CHCl3 at 7.260): 8.00 (dd-like, Jo = 7.3, Jm ≈ 1.4, Ho of PhSO2); 7.65 (tt, Jo = 7.4, Jm ≈ 
1.1, Hp of PhSO2); 7.58 (t, Jo = 7.7, Hm of PhSO2); 6.32 (s, H–C(10)); 6.28 (d, 3J(8,7) 
= 6.5, H–C(8)); 6.14 (dd-like, 3J(7,8) = 6.5, 4J(7, Me–C(6)) ≈ 1, H–C(7)); 6.02 (dd-
like, 3J(2,3) = 5.2, 4J(2,Me–C(1)) ≈ 0.7, H–C(2)); 3.98 (br. q, 3J(1’,Me–C(1’)) = 6.8, 
3J(1’,3) ≤ 0.6, H–C(1’)); 3.97 (d, 3J(4,3) = 3.3, H–C(4)); 3.85 (very br., slightly 
structured s, H–C(3)); 3.69 (s, MeOOC–C(5)); 3.48 (s, MeOOC–C(4)); 2.55 (sept, 
Me2CH–C(9)); 1.96 (s, Me–C(6)); 1.95 (t-like, 4J(Me–C(1’)) ≈ 2·5J(Me–C(1),10) ≈ 
1.3, Me–C(1)); 1.31 (d, 3J(Me–C(1’),1’) = 7.0, Me–C(1’)); 1.13/1.09 (2d, Jvic = 6.9, 
Me2CH–C(9)). 13C-NMR (150 MHz, CDCl3, 300 K; CDCl3 at 77.00): 171.14 
(MeOOC–C(4)); 167.52 (MeOOC–C(5)); 150.31 (C(5a)); 147.10 (C(9)); 138.29 (Cip 
of PhSO2); 133.98 (C(1)); 133.35 (Cp of PhSO2); 131.81 (C(10a)); 129.14 (Co of 
PhSO2); 129.09 (C(6)); 128.95 (Cm of PhSO2); 127.80 (C(2)); 127.08 (C(10)); 123.96 
(C(8)); 123.48 (C(7)); 121.32 (C(5)); 59.93 (C(1’)); 51.91 (MeOOC–C(5)); 51.75 
(MeOOC–C(4)); 44.71 (C(4)); 36.68 (C(3)); 35.95 (Me2CH–C(9)); 26.54 (Me–C(1)); 
24.41/22.46 (Me2CH–C(9)); 11.25 (Me–C(1’)). 
 
1.1.11.1. Dimethyl (P*,3S*,4S*)-9-Isopropyl-1,4,6-trimethyl-3-((S*)-1-phenylsulfo-
nyl)ethyl)-3,4-dihydroheptalene-4,5-dicarboxylate ((P*)-41). NaH (0.025 g, 1.05 
mmol; obtained from an NaH suspension in mineral oil by washing with hexane) in 
THF (0.5 mL) was cooled to –10°, followed by the addition of (P*)-23 (0.425 g, 0.83 
mmol, dissolved in THF (3 mL). The mixture was stirred for 4 h without further 
cooling and then was MeI (0.185 g, 0.08 mL, 1.30 mmol) added. After 3 d stirring at 
ambient temperature, water was added. The product was extracted with Et2O and 
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crystallized from this solvent, which gave (P*)-41 in pale yellow crystals (0.420 g, 
95%). 
 
Data of (P*)-41: M.p. 127 – 128°. IR (KBr): 1740s and 1701s (C=O, ester), 1325s 
and 1148s (sulfone). 1H-NMR (300 MHz, CDCl3, 300 K): 7.93 (d with f.s., Jo ≈ 8, Ho 
of PhSO2); 7.56 – 7.47 (superimp. signals of Hp and Hm of PhSO2); 6.35 (s, H–C(10)); 
6.28 (d, 3J(8,7) = 6.4, H–C(8)); 6.17(dd-like, 3J(2,3) = 6.0, 4J(2, Me–C(1)) = 1.1, H–
C(2)); 6.11 (dd-like, 3J(7,8) = 6.5, 4J(7,Me–C(6)) = 1.3, H–C(7)); 4.30 (br. q, 
3J(1’,Me–C(1’)) ≈ 6.5, H–C(1’)); 3.81 (s, MeOOC–C(5)); 3.57 (s, MeOOC–C(4)); 
3.08 (br. d, 3J(3,2) = 5.5, H–C(3)); 2.58 (sept, Me2CH–C(9)); 2.11 (s, Me–C(6)); 2.06 
(s, Me–C(1)); 1.66 (br. s, Me–C(4)); 1.51 (d, 3J(Me–C(1’),1’) = 7.0, Me–C(1’)); 1.15 
(d, Jvic = 6.9, pro-R Me of Me2CH–C(9)); 1.10 (d, Jvic = 6.8, pro-S Me of Me2CH–
C(9)). Relevant 1H-NOE: pro-R Me of Me2CH–C(9) ⇔ Me–C(4) and H–C(8); pro-S 
Me of Me2CH–C(9) ⇔ H–C(10); these 1H-NOE prove also the (P*)-configuration of 
the 3,4-dihydroheptalene skeleton and the (S)-configuration at C(4). 13C-NMR (75 
MHz,CDCl3, 300 K): 176.36 MeOOC–C(4)); 170.88 (MeOOC–C5)); 145.79 (C(9)); 
144.94 (C(5a)); 140.92 (Cip of PhSO2); 135.23 (C(1)); 132.64 (Cp of PhSO2); 131.04 
(C(6)); 130.74 (C(10a)); 128.77 (Co of PhSO2); 128.53 (Cm of PhSO2); 127.47 
(C(10)); 125.10 C(5)); 124.25 (C(2)); 124.11 (C(8)); 123.22 (C(7)); 61.89 (C(1’)); 
52.45 (MeOOC–C(5)); 52.05 (MeOOC–C(4)); 51.62 (C(4)); 50.09 (C(3)); 36.23 
(Me2CH–C(9)); 25.59 (Me–C(1)); 23.76 and 22.50 (Me2CH–C(9)); 23.18 (Me–C(6)); 
19.36 (Me–C(1’)). CI-MS: 525.2 (100, [M + 1]+), 493.2 (10, [(M + 1) – MeOH]+), 
404.2 (10), 386.2 (16), 286.1 (57), 257.2 (74, [(iPrMe2C10H5COOMe]+). 
The structure and relative configuration of (P*)-41 was finally proved by an X-ray 
crystal-structure analysis (cf. Table 7 and Fig. 4).   
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2. Formation of the 3,3-Dimethoxy-5-(1-(phenylsulfonyl)ethyl)-4,5-dihydrohepta-
leno[1,2-c]furan-1(3H)-ones. – 2.1. General Procedure. At 0° and under argon and 
stirring, a solution (1-(phenylsulfonyl)ethyl)lithium in THF (25 mL) is prepared from 
the sulfone (1.76 mmol) and BuLi (2.5 M in hexane; 2.20 mmol). The solution is than 
cooled to –78° and the 3,3-dimethoxy-1,3-dihydroheptaleno[4,5-c]furan-1-one (1.50 
mmol) in THF (5 mL) is added drop by drop. After 3 h stirring at –78°, the mixture is 
quenched with ice-cooled aq. HCl (17%). After extraction with AcOEt, the AcOEt 
phase is washed and dried (Na2SO4). The residue of the AcOEt phase is then re-
crystallized. 
 
2.1.1. (P*,5S*)- and (M*,5S*)-8-Isopropyl-3,3-dimethoxy-6,11-dimethyl-5-((R*)-1-
(phenylsulfonyl)ethyl)-4,5-dihydroheptaleno[1,2-c]furan-1-(3H)-one ((P*)- and (M*)-
27). Furan-1-one 25 (0.50 g, 1.47 mmol) [7] was reacted with EtSO2Ph (0.306 g, 1.76 
mmol) under the standard conditions and gave, after re-crystallization from Et2O, 
(P*)-27 in pale yellow crystals (0.625 g, 92%). Dissolution of the crystals in CDCl3 at 
243 K showed only the presence of (P*)-27 (1H-NMR); at ambient temperature, a 64 : 
36 mixture of (P*)- and (M*)-27 was established in a short time. 
 
Data of (P*)-27: M.p. 158.0 – 160.1°. Rf (AcOEt/hexane 1 : 2) 0.59. IR (KBr): 1768s 
(C=O, five-ring lactone). 1H-NMR (600 MHz, CDCl3, 300 K, in the presence of 36% 
of (M*)-27; CHCl3 at 7.264): 7.765 (dd-like, Jo = 8.3, Jm = 1.1, Ho of PhSO2); 7.627 
(tt-like, J = 7.5, 1.1, Hp of PhSO2); 7.504 (t with f.s., J = 7.9, Hm of PhSO2); 6.318 (dd, 
3J(9,10) = 11.8, 4J(9,7) = 1.1, H–C(9)); 6.225 (d, 3J(10,9) = 11.9, H–C(10)); 5.838 (br. 
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s, H–C(7)); 3.472 (s, (MeO)2–C(3))17); 3.409 (br. dt-like, 3J(5,4R) = 12.6, Σ 3J(5,4S) + 
3J(5,1’) = 4.4, H–C(5)); 3.339 (qd, 3J(1’,Me–C(1’)) = 7.1, 3J(1’,5) = 2.4, H–C(1’));  
2.842 (dd, 2J(HS,HR) = 20.0, 3J(HS,5) = 2.0, HS–C(4)); 2.458 (sept, Me2CH–C(8)); 
2.255 (dd, 2J(HR,HS) = 20.0, 3J(HR,5) = 12.5, HR–C(4); 1.967 (s, Me–C(11)); 1.590 (d-
like, 5J(Me–C(6),7) ≈ 0.8, Me–C(6)); 1.526 (d, 3J(Me–C(1’),1’) = 7.1, Me–C(1’)); 
1.073/1.062 (2d, t-like superimp., 3J = 6.7/6.6, Me2CH–C(8)). 13C-NMR (150 MHz, 
CDCl3, 300 K, in the presence of 36% of (M*)-27; CDCl3 at 77.00): 166.27 (C(1)); 
158.71 (C(3a)); 144.13 (C(8)); 137.75 (C(11)); 137.47 (Cip of PhSO2); 134.77 (C(6a)); 
133.82 (C(10)); 133.52 (Cp of PhSO2); 131.74 (C(9)); 129.35 (C(11b)); 129.11 (Cm of 
PhSO2); 128.82 (C(6)); 128.67 (Co of PhSO2); 121.42 (C(7)); 119.47 (C(11a)); 118.46 
(C(3)); 59.89 (C(1’)); 51.59 (MeO–C(3), pro-R); 51.48 (MeO–C(3), pro-S); 35.39 
(C(5)); 34.37 (Me2CH–C(8)); 24.19 (C(4)); 22.76/22.41 (Me2CH–C(8)); 22.41 (Me–
C(11)); 12.08 (Me–C(6)); 9.99 (Me–C(1’)). CI-MS: 533.1 (100, [M + Na]+), 391.1 
(15, [(M + Na) – PhSO2H]+). 
 
Data of (M*)-27: 1H-NMR (600 MHz, CDCl3, 300 K, in the presence of 64% of (P*)-
27; CHCl3 at 7.264): 7.726 (dd-like, Jo = 8.3, Jm = 1.1, Ho of PhSO2); 7.583 (tt-like, J 
= 7.5, 1.1, Hp of PhSO2); 7.463 (t with f.s., J = 7.9, Hm of PhSO2); 6.456 (dd, 3J(9,10) 
= 11.8, 4J(9,7) = 1.1, H–C(9)); 6.365 (d, 3J(10,9) = 11.8, H–C(10)); 5.744 (br. s, H–
C(7)); 3.783 (qd, 3J(1’,Me–C(1’)) = 7.2, 3J(1’,5) = 9.5, H–C(1’)); 3.460 (s, MeO–
C(3), pro-R); 3.290 (s, MeO–C(3), pro-S); 3.783 (ddd, Σ 3J(5,4R)  + 3J(5,4S) + 3J(5,1’) 
= 17.9, H–C(5)); 2.656 (dd, 2J(HR,HS) = 21.0, 3J(HR,5) = 3.4, HR–C(4); 2.523 (dd, 
2J(HS,HR) = 21.0, 3J(HS,5) = 4.6, HS–C(4)); 2.469 (sept, Me2CH–C(8)); 1.930 (s, Me–
                                                
17) At 243 K, one finds two s at 3.458 and 3.425, corresponding presumably to the 
pro-R and pro-S group, respectively. 
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C(11)); 1.599 (d, 5J(Me–C(6),7) = 1.0, Me–C(6)); 1.231 (d, 3J(Me–C(1’),1’) = 7.2, 
Me–C(1’)); 1.108/1.090 (2d,  3J = 6.9/6.8, Me2CH–C(8)). 13C-NMR (150 MHz, 
CDCl3, 300 K, in the presence of 36% of (P*)-27; CDCl3 at 77.00): 166.12 (C(1)); 
157.67 (C(3a)); 143.55 (C(8)); 138.53 (Cip of PhSO2); 137.72 (C(11)); 133.63 (C(9)); 
133.34 (Cp of PhSO2); 133.20 (C(10)); 133.10 (C(6)); 131.79 (C(6a)); 129.35 (Cm of 
PhSO2); 128.88 (C(11b)); 128.67 (Co of PhSO2); 122.76 (C(7)); 120.33 (C(11a)); 
118.08 (C(3)); 60.91 (C(1’)); 51.68 (MeO–C(3), pro-R); 51.51 (MeO–C(3), pro-S); 
39.81 (C(5)); 34.31 (Me2CH–C(8)); 25.58 (C(4)); 22.77/22.69 (Me2CH–C(8)); 22.54 
(Me–C(11)); 18.81 (Me–C(6)); 12.76 (Me–C(1’)).   
 
2.1.2. (P*,5S*)-3,3-Dimethoxy-7,9,11-trimethyl-5-((R*)-1-(phenylsulfonyl)ethyl)-4,5-
dihydroheptaleno[1,2-c]furan-1(3H)-one ((P*)-30). Furanone 28 (0.50 g, 1.60 
mmol)18) in THF (5 mL) was reacted with EtSO2Ph (0.327 g, 1.92 mmol) in THF (20 
mL) as described. Working up followed by chromatography on silica gel (hexane/ 
AcOEt 3 : 1) and crystallization from AcOEt/hexane gave pure (P*)-30 in pale yellow 
crystals (0.530 g, 69%).  
 
Data of (P*)-30: M.p. 196.3 – 197.3°. Rf (hexane/AcOEt 3 : 2) 0.49. IR (KBr): 1766s 
(C=O, five-ring lactone). 1H-NMR (500 MHz, CDCl3, 300 K; CHCl3 at 7.264): 7.803 
(d with f.s., Jo = 7.3, Ho of PhSO2); 7.640 (t, Jo = 7.5, Hp of PhSO2); 7.520 (t, Jo = 7.8, 
Hm of PhSO2); 6.124 (br. s,  H–C(10)); 5.880 (br. s, H–C(8)); 5.342 (d, 3J(6,5) = 6.8, 
H–C(6)); 3.442 (s, MeO–C(3), pro-R); 3.338 (s, MeO–C(3), pro-S); 3.26 – 3.19 
                                                
18) The semi-orthoanhydride 28 (m.p. 118.0 – 119.0° (Et2O/hexane)) was pre-
pared from the corresponding heptalene half-ester in the described manner [7] 
(for spectral details see [12]).  
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(superimp. signals of H–C(1’) and H–C(5)); 2.923 (dd, 2J(HS,HR) = 20.2, 3J(HS,5) = 
2.8, HS–C(4)); 2.318 (dd, 2J(HR,HS) = 20.2, 3J(HR,5) = 12.4, HR–C(4)); 2.004 (s, Me–
C(9)); 1.984 (s, Me–C(7)); 1.960 (s, Me–C(11)); 1.372 (d, 3J(Me–C(1’),1’) = 6.9, 
Me–C(1’)). 1H-NMR (600 MHz, [2H6]acetone, 300 K): 7.74 Ho of PhSO2); 7.64 (Hp of 
PhSO2); 7.53 (Hm of PhSO2); 6.04 (br. s, H–C(10)); 5.80 (t-like, J ≈ 1.2, H–C(8)); 
5.43 (d, 3J(6,5) = 7.2, H–C(6)); 3.34 (qd, 3J(1’, Me–C(1’) = 7.2, 3J(1’,5) ≈ 3.6, H–
C(1’)); 3.31 (s, MeO–C(3), pro-R); 3.18 (s, MeO–C(3), pro-S); 3.06 (dquint, 3J(5,HR) 
= 12.6, 3J(5,6) = 7.2, 3J(5,HS) ≈ 3J(5,1’) ≈ 3.3–3.6, H–C(5)); 2.81 (dd, 2J(HS,HR) = 
20.4, 3J(HS,5) = 3.6, HS–C(4)); 2.28 (dd, 2J(HR,HS) = 20.4, 3J(HR,5) = 12.6, HR–C(4)); 
1.86 (d-like, 4J ≈ 1, Me–C(9)); 1.85 (d-like, 4J ≈ 1, Me–C(7)); 1.78 (s, Me–C(11)); 
1.24 (d, 3J(Me–C(1’),1’) = 7.2, Me–C(1’)). 13C-NMR (125 MHz, CDCl3, 300 K; 
CDCl3 at 77.00): 166.43 (C(1)); 157.48 (C(3a)); 144.66 (C(6a)); 139.55 (C(9)); 
139.29 (C(11)); 137.78 (Cip of PhSO2); 136.35 (C(7)); 133.68 (Cp of PhSO2); 129.95 
(C(10)); 129.09 (Cm of PhSO2); 128.92 (C(11b)); 128.78 (Co of PhSO2); 126.66 
(C(8)); 123.52 (C(6)); 118.49 (C(3)); 113.61 (C(11a)); 62.49 (C(1’)); 51.59 (MeO–
C(3), pro-R); 51.27 (MeO–C(3), pro-S); 33.25 (C(5)); 25.91 (C(4)); 25.60 (Me-C(9)); 
24.72 (Me–C(7)); 23.28 (Me–C(11)); 10.41 (Me–C(1’)). CI-MS: 505.1 (100, [M + 
Na]+), 363.1 (6, [(M + Na) – PhSO2H]+). 
The relative configuration of (P*)-30 was established by an X-ray crystal-structure 
analysis (see Fig. X and Table 7). 
 
Heating of pure (P*)-30 in CDCl3 at 45° gave after 2 h about 10% of (P*,5S*)-3,3-
dimethoxy-7,9,11-trimethyl-5-((S*)-1-(phenylsulfonyl)ethyl)-4,5-dihydroheptaleno-
[1,2-c]furan-1(3H)-one, and, after further heating for 6 h at 45°, a 2 : 1 ratio of (P*)-
30 and its C(1’)-epimer. Epimerization at the heptalene axis of chirality was not 
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observed. Moreover, heating of pure (P*)-30 in [2H6]acetone at 45° (4 h) left the 
compound unchanged.  
Data of (P*,5S*)-3,3-dimethoxy-7,9,11-trimethyl-5-((S*)-1-(phenylsulfonyl)ethyl)-
4,5-dihydroheptaleno[1,2-c]furan-1(3H)-one: 1H-NMR (600 MHz, CDCl3, 300 K, in 
the presence of 66% of (P*)-30; CHCl3 at 7.264): 7.83 (d, Ho of PhSO2); 7.65 (t, Hp of 
PhSO2); (t, Hm of PhSO2); 6.18 (s, H–C(10)); 5.92 (s, H–C(8)); 5.41 (d, 3J(6,5) = 7.2, 
H–C(6)); 3.44 (s, MeO–C(3), pro-R); 3.34 (s, MeO–C(3), pro-S); 3.25 – 3.18 (m, H–
C(1’) and H–C(5) of (P*)- and (M*)-form); 2.52 (dd, 2J(HR,HS) = 20.3, 3J(HR,5) = 
12.5, HR–C(4)); 2.36 – 2.29 (HS–C(4), covered by HR–C(4) of (P*)-form); 2.03 (s, 
Me–C(9)); 2.02 (s, Me–C(7)); 2.01 (s, Me–C(11)); 1.37 (d, 3J(Me–C(1’),1’) = 7.1, 
Me–C(1’)). 
 
 2.1.3. (P*,5R*)-3,3-Dimethoxy-6,7,9,11-tetramethyl-5-((S*)-1-(phenylsulfonyl)ethyl)-
4,5-dihydroheptaleno[1,2-c]furan-1-one ((P*)-31). Furanone 29 (0.180 g, 0.55 mmol) 
[7] in THF (5 mL) was reacted with EtSO2Ph (0.204 g, 1.20 mmol) in THF (10 mL) 
as described. Workup followed by chromatography on silica gel (hexane/AcOEt 5 : 2) 
and crystallization from AcOEt/hexane gave pure (P*)-31 in pale yellow crystals 
(0.378 g, 64%). 
 
Data of (P*)-31: M.p. 211.9 – 212.4°. Rf (hexane/AcOEt 3 : 1) 0.34. IR (KBr): 1775s 
(C=O, five-ring lactone). 1H-NMR (500 MHz, CDCl3, 300 K; CHCl3 at 7.263): 7.734 
(d with f.s., Jo = 8.2, Ho of PhSO2); 7.610 (tt, Jo = 7.5, Jm = 1.2, Hp of PhSO2); 7.495 (t 
with f.s., Jo = 7.5, Hm of PhSO2); 6.165 (br. s,  H–C(10)); 5.948 (br. s, H–C(8)); 3.749 
(qd, 3J(1’,5) = 9.3, 3J(1’,Me–C(1’)) = 7.2, H–C(1’)); 3.489 (s, MeO–C(3), pro-R); 
3.236 (s, MeO–C(3), pro-S); ; 2.922 (ddd, Σ 3J(5,4R)  + 3J(5,4S) + 3J(5,1’) = 17.4, H–
C(5)); 2.677 (dd, 2J(HS,HR) = 21.0, 3J(HS,5) = 3.5, HS–C(4)); 2.517 (dd, 2J(HR,HS) = 
21.0, 3J(HR,5) = 4.6, HR–C(4)); 2.083 (d, 4J(Me–C(9),10) = 0.9, Me–C(9)); 1.893 (d, 
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4J(Me–C(7),8) = 1.2, Me–C(7)); 1.885 (s, Me–C(11)); 1.694 (s, Me–C(6)); 1.200 (d, 
3J(Me–C(1’),1’) = 7.2, Me–C(1’)). 13C-NMR (125 MHz, CDCl3, 300 K; CDCl3 at 
77.00): 166.17 (C(1)); 157.49 (C(3a)); 141.23 (C(9)); 138.44 (Cip of PhSO2); 136.78 
(C(11)); 135.84 (C(7)); 133.42 (Cp of PhSO2); 132.63 (C(6a)); 132.57 (C(6)); 129.55 
(C(10)); 128.83 (Cm of PhSO2); 128.64 (C(11b)); 128.60 (Co of PhSO2); 126.78 
(C(8)); 118.24 (C(3)); 115.91 (C(11a)); 61.31 (C(1’)); 51.58 (MeO–C(3), pro-R); 
51.23 (MeO–C(3), pro-S); 39.29 (C(5)); 26.27 (C(4)); 25.11 (Me-C(9)); 22.70 (Me–
C(7)); 21.93 (Me–C(11)); 19.90 (Me–C(6)); 13.21 (Me–C(1’)). CI-MS: 519.1 (100, 
[M + Na]+), 377.2 (7, [(M + Na) – PhSO2H]+).  
The relative configuration of (P*)-31 was established by an X-ray crystal-structure 
determination (see Fig. X and Table Y). 
 
2.1.4. Methyl 8-(tert-Butyl)-1-methyl-5-(2-(phenylsulfonyl)propanoyl)heptalene-4-
carboxylate (33) and (P*,5S*)-9-(tert-Butyl)-3,3-dimethoxy-6-methyl-5-((R*)-1-(phe-
nylsulfonyl)ethyl)-4,5-dihydroheptaleno[1,2-c]furan-1-one ((P*)-34). Furanone 32 
(0.340 g, 1.00 mmol)19) in THF (5 mL) was reacted in the usual manner with EtSO2Ph 
(0.204 g, 1.20 mmol) in THF (10 mL). Workup followed by chromatography on silica 
gel (hexane/AcOEt 5 : 2) gave after crystallization from Et2O/hexane 33 (0.378 g, 
79%) as an orange crystal powder. (P*)-34 could be enriched (in total <5 %) in the 
mother liquor. 
 
                                                
19) The semi-orthoanhydride 32 (m.p. 162.0 – 163.0° (Et2O/hexane)) was pre-
pared from the corresponding heptalene half-ester in the described manner [7] 
(for spectral details see [13]).  
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Data of 33: M.p. 136.5 – 140.5°. Rf (hexane/AcOEt 5 : 2) 0.28. The compound 
formed in CDCl3 solution a 3 : 1 mixture, presumably of the (P*)- and (M*)-epimers, 
with unknown relative configuration of the 2-(phenylsulfonyl)propanoyl substituent at 
C(5). 1H-NMR (300 MHz, CDCl3, 300 K; major epimer): 7.84 (d, Jo = 7.4, Ho of 
PhSO2); 7.66 (t-like, Hp of PhSO2); 7.55 (t-like, Hm of PhSO2); 7.47 (d, 3J(3,2) = 6.2, 
H–C(3)); 6.39 (d, 3J(9,10) = 7.0, H–C(9)); 6.38 (d, 3J(7,6) = 11.5, H–C(7)); 6.02 (d, 
3J(6,7) = 11.5, H–C(6)); 5.91 (superimp. d, 3J = 7.0, H–C(2,10)); 4.11 (q, 3J = 6.9, H–
C(2’)); 3.71 (s, MeOOC–C(4)); 2.00 (s, Me–C(1)); 1.46 (d, 3J = 6.9, Me–C(2’)); 1.16 
(s, Me3C–C(8)). 1H-NMR (300 MHz, CDCl3, 300 K; minor epimer): 7.99 (d, Jo = 7.6, 
Ho of PhSO2); 7.64 (t-like, Hp of PhSO2); 7.54 (t-like, Hm of PhSO2); 7.38 (d, 3J(3,2) = 
6.3, H–C(3)); 6.73 (d, 3J(7,6) = 11.2, H–C(7)); 6.56 (d, 3J(9,10) = 6.6, H–C(9)); 6.29 
(d, 3J(6,7) = 11.2, H–C(6)); 6.09 (d with f.s., 3J(2,3) = 6.3, H–C(2)); 6.00 (d, 3J(10,9) 
= 7, H–C(10)); 4.87 (q, 3J = 6.8, H–C(2’)); 3.55 (s, MeOOC–C(4)); 2.03 (s, Me–
C(1)); 1.46 (d, 3J = 6.9, Me–C(2’)); 1.20 (s, Me3C–C(8)). 13C-NMR (75 MHz, CDCl3, 
300 K; major epimer): 191.41 (C(1’)); 167.49 (MeOOC–C(4)); 154.70 (C(8)); 146.46 
(C(1)); 143.85 (C(3)); 143.76 (C(5a)); 137.92 (Cip of PhSO2); 133.69 (Cp of PhSO2); 
133.50 (C(10a)); 132.61 (C(4)); 131.07 (C(7)); 129.00  (Co of PhSO2); 128.86 
(C(10)); 128.62 (Cm of PhSO2); 124.31 (C(9)); 125.88 (C(2)); 123.90 (C(6)); 122.10 
(C(5)); 68.86 (C(2’)); 52.28 (MeOOC–C(4)); 36.23 Me3C–C(8)); 29.90 (Me3C–C(8)); 
26.37 (Me–C(1)); 11.91 (Me–C(2’)). 
 
Data of (P*)-34: Enrichment ca. 80 %. Relative configuration in analogy to (P*)-27 
and (P*)-31 presumably (P*,1’S*,5R*). 1H-NMR (300 MHz, CDCl3, 300 K): 7.81 (d-
like, Jo ≈ 7.1, Ho of PhSO2); 7.66 (t-like, Jo ≈ 7.3, Hp of PhSO2); 7.56 (t-like, Hm of 
PhSO2); 6.91 (d, 3J(10,11) = 7.1, H–C(10)); 6.29 (d, 3J(11,10) = 7.1, H–C(11)); 6.24 
(dd-like, 3J(7,8) = 11.3, 5J(7,Me–C(6)) ≈ 1.6, H–C(7)); 5.90 (d, 3J(8,7) = 11.3, H–
  ’   41 
C(8)); 3.53 (s, MeO–C(3), pro-R); 3.45 (s, MeO–C(3), pro-S); 3.60 – 3.40  (superimp. 
signals of H–C(1’) and HS–C(4)); 2.90 (dt-like, 3J(5,HS) ≈ 10.8, H–C(5)); 2.74 (dd, 
2J(HR,HS) = 20.7, 3J(HR,5) = 3.6, HR–C(4)); 1.75 (d, 5J(Me–C(6),7) ≈ 1.1, Me–C(6)); 
1.10 (s, Me3C–C(9)); 0.93 (d, 3J = 7.0, Me–C(1’)). 13C-NMR (75 MHz, CDCl3, 300 K; 
some assignments are tentative): 167.46 (C(1)); 154.59 (C(9)); 154.33 (C(3a)); 137.49 
(Cip of PhSO2); 133.60 (Cp of PhSO2); 129.05 (Cm of PhSO2); 128.80 (Co of PhSO2); 
127.95 (C(8)); 126.49 (C(11); 126.40 (C(10)); 122.04 (C(7)); 118.51 (C(3)); residual 
signals in the range of 150 – 120 not assignable; 59.46 (C(1’)); 51.92 (MeO–C(3), 
pro-R); 51.48 (MeO–C(3), pro-S); 42.03 (C(5)); 35.48 (Me3C–C(9)); 29.83 (Me3C–
C(9)); 21.24 (Me–C(6)); 13.86 (Me–C(1’)). 
 
3. Formation of the Alkylated Dimethyl Heptalene-4,5- and -1,2-dicarboxylates 
by Base-Catalyzed Elimination of Benzenesulfinic Acid from the Corresponding 
Sulfones. – 3.1. Standard Procedure. Sodium methoxide (2.2 mmol) is freshly 
prepared from Na in MeOH (3 mL). The sulfone (2.2 mmol) is added in THF (3 mL) 
and the mixture heated at reflux for 3 to 12 h. Then, after cooling, aq. 1N HCl is added 
and the mixture extracted with Et2O. The thus obtained dimethyl heptalenedicarb-
oxylate, in some cases accompanied by the corresponding cyclic anhydride, is puri-
fied by chromatography on silica gel.  
 
3.1.1. Dimethyl 3-Methylheptalene-4,5-dicarboxylate (36) and Dimethyl 3-Methyl-
heptalene-4,5-dicarboxylic anhydride (4-methylheptaleno[4,5-c]furan-1,3-dione; 43). 
3.1.1.1. With MeONa/MeOH: Sulfone (P*)/(M*)-2 (0.150 g, 0.352 mmol) was heated 
for 12 h under the standard conditions and then worked up, which gave mainly 43 
(0.045 g, 54%) as a dark red oil and only trace amounts (< 2%) of 36.  
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Data of 43: IR (film): 1790.5s and 1740s (C=O, 5-ring anhydride). 1H-NMR (300 
MHz, CDCl3, 300 K; CHCl3 at 7.260): 6.60 (d, 3J(6,7) = 11.4, H–C(6)); 6.45 (dd, 
3J(9,8) = 10.8, 3J(9,10) = 7.6, H–C(9)); 6.37 (ddd, 3J(7,6) = 11.4, 3J(7,8) = 7.1, 4J(7,9) 
= 1.1, H–C(7)); 6.21 (ddd, 3J(8,9) = 10.8, 3J(8,7) = 7.1, 4J(8,6) = 0.7, H–C(8)); 5.76 
(d, 3J(1,2) = 11.4, H–C(1)); 5.48 (d, 3J(10,9) = 7.6, H–C(10)); 5.33 (d, 3J(2,1) = 11.3, 
H–C(2)); 2.36 (s, Me–C(3)). 13C-NMR (75 MHz, CDCl3, 300 K; CDCl3 at 77.00): 
163.75 and 160.22 (C=O, 5-ring anhydride); 151.05; 148.58; 139.09; 137.92; 136.52; 
135.92; 135.73; 135.25; 133.58; 128.80; 126.47; 118.94; 20.85 (Me–C(3)). EI-MS: 
238 (55, M+), 181 (20), 165 (25), 153 (30); 134 (25); 109 (65), 95 (100).  
 
3.1.1.2. With t-BuOK: Sulfone (P*)/(M*)-2 (0.150 g, 0.352 mmol) was dissolved in 
THF (3 mL) and t-BuOK (0.080 g, 0.69 mmol) in THF (1 mL) was added. After 2 h 
stirring at ambient temperature, work up was performed under the standard condition 
to yield 36 as orange colored oil (0.031 g, 31%).  
 
Data of 36: 1H-NMR (300 MHz, CDCl3, 300 K): 6.50 – 5.70 (m, 7 H); 2.26 (s, Me–
C(3)). EI-MS: 284 (52, M+), 186 (100, [M – MeC≡CCOOMe]+). 
 
3.1.2. Dimethyl 1,3,6-Trimethylheptalene-4,5-dicarboxylate (38) and Dimethyl 3,5,10-
Trimethylheptalene-1,2-dicarboxylate (38’). Sulfone (P*)-10 (0.060 g, 0.132 mmol) 
was reacted for 12 h and then worked up under the standard conditions to yield a 
thermally equilibrated 2 : 1 mixture of 38 and 38’ (0.027 g, 66%) as a dark yellow oil. 
IR (film): 1726s and 1709s (C=O, ester). EI-MS: 312 (90, M+), 297 (77, [M – Me]+), 
214 (100, [M – MeC≡CCOOMe]+). 
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Data of 38: 1H-NMR (300 MHz, CDCl3, 300 K; 67% in the mixture of DBS isomers): 
ca. 6.49 (3J = 6.5, H–C(7,10)); ca. 6.21 (signals superimp. with those of H–C(7) of 
38’, H–C(8) or H–C(9)); 6.01 (d-like, 4J(2,Me–C(1)) = 1.4, H–C(2)); ca. 5.95 (signals 
superimp. with those of H–C(6) of 38’, H–C(9) or H–C(8)); 3.68 (s, MeOOC-C(5)); 
3.62 (s, MeOOC–C(4)); 2.26 (s, Me–C(3)); 2.03 (d, 4J(Me–C(1),2) = 1.3, Me–C(1)); 
2.00 (d, 4J(Me–C(6),7) = 1.4, Me–C(6)).  
 
Data of 38’: 1H-NMR (300 MHz, CDCl3, 300 K; 33% in the mixture of DBS iso-
mers): 6.43 (s, H–C(4)); 6.42 (d, 3J(9,8) = 11.4, H–C(9)); 6.38 (dd, 3J(8,9) = 11.3, 
3J(8,7) = 5.6, H–C(8)); 6.22 (dd, partly covered by signals of 38, 3J(7,8) = 5.6, H–
C(7)); ca. 5.95 (d, mostly covered by signals of 38, 3J(6,7) ≈ 11, H–C(6)); 3.90 (s, 
MeOOC-C(5)); 3.66 (s, MeOOC–C(4)); 2.01 (d, 4J(Me–C(3),4 = 1.2, Me–C(3)); 1.75 
(s, Me–C(10)); 1.67 (s, Me–C(5)). 
 
3.1.2. Dimethyl 1,3,6,10-Tetramethylheptalene-4,5-dicarboxylate (39) and Dimethyl 
3,5,6,10-Tetramethylheptalene-1,2-dicarboxylate (39’). Sulfone (P*)/(M*)-12 (0.100 
g, 0.229 mmol) was reacted for 12 h and then worked up under the standard 
conditions. The thermally equilibrated 2 : 1 mixture of 39 and 39’ was separated by 
TLC on silica gel (hexane/Et2O 4 : 1) to give , after crystallization from Et2O/hexane 
1 : 4, pure 39 (0.013 g, 18%) and pure 39’ (0.007 g, 9%).  
 
Data of 39: M.p. 145 – 146°. IR (KBr): 1724s and 1704s (C=O, ester). 1H-NMR (300 
MHz, CDCl3, 300 K; CHCl3 at 7.260): 6.44 (dd, 3J(8,9) = 11.3, 3J(8,7) = 6.0, H–C(8)); 
6.37 (d, 3J(9,8) = 11.3, H–C(9)); 6.13 (dd-like, 3J(7,8) = 5.8, H–C(7)); 6.09 (d-like, 
4J(2,Me–C(1)) = 1.4, H–C(2)); 3.66 (s, MeOOC–C(5)); 3.60 (s, MeOOC–C(4)); 2.27 
(s, Me–C(3)); 1.98 (t-like, 4J(Me–C(6),7) ≈ 2 × 5J(Me–C(6),8) = 1.3, Me–C(6)); 1.94 
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(d, 4J(Me–C(1),2) = 1.4, Me–C(1)); 1.79 (s, Me–C(10)). 13C-NMR (75 MHz, CDCl3, 
300 K; CDCl3 at 77.00): 168.10 (MeOOC–C(4)); 167.45 (MeOOC–C(5)); 148.03 
(C(3)); 147.00 (C(5a)); 140.07 (C(6)); 132.72 (C(8)); 132.11 (C(9)); 131.69 (C(1)); 
130.20 (C(7)); 129.20 (C(10)); 127.48 (C(4)); 126.94 (C(10a)); 124.49 (C(2)); 122.78 
(C(5)); 51.78 (MeOOC–C(5)); 51.46 (MeOOC–C(4)); 22.70 (Me–C(1)); 22.25/22.13 
(Me–C(6,10)); 18.07 (Me–C(3)). EI-MS: 326 (79, M+), 311 (60, [M – Me]+), 267 (31, 
[M – COOMe]+), 252 (24, [M – (COOMe + Me)]+), 228 (100, [M – 
MeC≡CCOOMe]+). 
 
Data of 39’: M.p. 131 – 132°. 1H-NMR (300 MHz, CDCl3, 300 K; CHCl3 at 7.260): 
6.45 (d-like, 4J(4,Me–C(3)) = 1.2, H–C(4)); 6.32 (dd, 3J(8,9) = 11.1, 3J(8,7) = 6.3, H–
C(8)); 6.30 (d, 3J(9,8) = 11.1, H–C(9)); 6.15 (dd-like, 3J(7,8) = 6.3, 4J(7,Me–C(6)) ≈ 
1.5, H–C(7)); 3.69 (s, MeOOC–C(5)); 3.67 (s, MeOOC–C(4)); 2.03 (d, 4J(Me–C(3),4) 
= 1.2, Me–C(3)); 1.99 (d, 4J(Me–C(6),7) = 1.5, Me–C(6)); 1.76 (s, Me–C(10)); 1.67 
(s, Me–C(5)). EI-MS: 326 (100, M+), 311 (94, [M – Me]+), 295 (22, [M – MeO]+), 267 
(18, [M – COOMe]+), 252 (35, [M – (COOMe + Me]+), 228 (73, [M – 
MeC≡CCOOMe]+). 
 
3.1.4. Dimethyl 9-Isopropyl-1,3,6-trimethylheptalene-4,5-dicarboxylate (35), 
Dimethyl 7-Isopropyl-3,5,10-trimethylheptalene-1,2-dicarboxylate (35’), and 9-
Isopropyl-1,3,6-trimethyl-4,5-dicarboxylic Anhydride (8-isopropyl-4,6,11-trimethyl-
heptaleno[4,5-c]furan-1,3-dione; 44). 3.1.4.1. With MeONa/MeOH: Following the 
standard procedure, sulfone (P*)-15 (0.080 g, 0.161 mmol) yielded after 12 h a 3 : 2 
mixture of 35 and 35’ (0.022 g, 39%) (cf. [9]).  
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Data of 35: M.p., UV, and IR, see [9]. We report here again the 1H-NMR since the 
locants of the heptalene skeleton had been reversed in the meantime according to the 
IUPAC rules (C(5) old → C(1) new, etc.), and some atomic positions of 35 and of 35’ 
had to be reassigned according to our new full 1H,13C analysis. 1H-NMR (600 MHz, 
CDCl3, 300 K, CHCl3 at 7.270; 60% of 35): 6.291 (d, 3J(8,7) = 6.6, H–C(8)); 6.134 
(dd-like, 3J(7,8) = 6.5, 4J(7,Me–C(6)) = 1.0, H–C(7)); 6.006 (d-like, 4J(2,Me–C(1)) = 
1.2, H–C(2)); 5.862 (s, H–C(10)); 3.685 (s, MeOOC–C(5)); 3.625 (s, MeOOC–C(4)); 
2.500 (sept, Me2CH–C(9)); 2.269 (s, Me–C(3)); 2.019 (d, 4J(Me–C(1),2) = 1.3, Me–
C(1)); 2.003 (s, Me–C(6)); 1.102 and 1.069 (2d, Jvic = 6.9 and 6.8, Me2CH–C(9)). 
13C-NMR (150 MHz, CDCl3, 300 K, CDCl3 at 77.00; 60% of 35): 168.12 (MeOOC-
C(4)); 167.74 (MeOOC–C(5)); 148.27 (C(3)); 148.10 (C(9)); 145.71 (C(5a)); 141.31 
(C(1)); 131.70 (C(2)); 131.39 (C(10a)); 128.81 (C6)); 127.91 (C(4)); 126.10 (C(7)); 
125.07 (C(8)); 124.39 (C(10)); 123.16 (C(5)); 51.89 (MeOOC–C(5)); 51.45 
(MeOOC–C(4)); 35.58 (Me2CH–C(9)); 25.11 (Me–C(1)); 22.98 and 22.59 (Me2CH-
C(9)); 22.71 (Me–C(3)); 22.57 (Me–C(6)). GC-MS: 354 (60, M+), 339 (50, [M – 
Me]+), 295 (10, [M – COOMe]+), 256 (100, [M – MeC≡CCOOMe]+). 
 
Data of 35’: 1H-NMR (600 MHz, CDCl3, 300 K, CHCl3 at 7.270; 40% of 35’; see also 
[9]): 6.438 (br. s, H–C(4)); 6.378 (d, 3J(9,8) = 11.9, H–C(9)); 6.345 (dd-like, 3J(8,9) = 
11.9, 4J(8,6) ≈ 1.0, H–C(8)); 5.730 (s, H–C(6)); 3.878 (s, MeOOC–C(5)); 3.658 (s, 
MeOOC–C(4)); 2.543 (sept, Me2CH–C(7)); 2.008 (d, 4J(Me–C(5),4) = 1.1, Me–C(5)); 
1.746 (s, Me–C(3)); 1.652 (s, Me–C(10)); 1.134 and 1.127 (2d, Jvic = 6.9 and 6.8, 
Me2CH–C(7)). 13C-NMR (150 MHz, CDCl3, 300 K, CDCl3 at 77.00; 40 % of 35’): 
168.90 (MeOOC–C(5)); 165.43 (MeOOC–C(4)); 148.40 (C(7)); 146.06 (C(5a)); 
138.89 (C(4)); 135.51 (C9)); 135.48 (C(2)); 132.96 (C(10)); 132.90 (C(5)); 131.98 
(C(8)); 129.67 (C(3)); 127.50 (C(10a)); 121.83 (C(6)); 120.52 (C(1)); 52.41 
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(MeOOC–C(5)); 52.29 (MeOOC–C(4)); 34.84 (Me2CH–C(7)); 22.88 and 22.63 
(Me2CH–C(7)); 22.48 (Me–C(5)); 17.37 (Me–C(10)); 17.15 (Me–C(3)). 
 
3.1.4.2. With t-BuOK: Treatment of sulfone (P*)-12 (0.130 g, 0.262 mmol) according 
to 3.1.1.2 gave after chromatographic separation on silica gel (hexane/AcOEt 2 : 1) a 
3 : 2 mixture of 35 and 35’ (0.021 g, 23%) and, after crystallization from 
AcOEt/hexane 1 : 2, orange colored crystals of 44 (0.016 g, 20%). 
 
Data of 44: M.p. 141 – 142°. IR (KBr): 1806s and 1754s (5-ring anhydride). 1H-NMR 
(300 MHz, CDCl3, 300 K): 6.40 (dd-like, 3J(7,8) = 7.0, 4J(7,Me–C(6)) = 1.3, H–C(7)); 
6.26 (d, 3J(8,7) = 7.0, H–C(8)); 6.17 (br. s, H–C(2)); 5.93 (s, H–C(10)); 2.49 (sept, 
partly covered by signal of Me–C(3), Me2CH–C(9)); 2.45 (s, Me–C(3)); 2.29 (s, Me–
C(1)); 2.17 (s, Me–C(6)); 1.10 and 1.08 (2d, Jvic = 6.7 and 6.6, Me2CH–C(9). CI-MS: 
326.2 (100, [M + NH4]+), 309.2 (80, [M + 1]+). 
 
3.1.5. Dimethyl 3-Ethyl-9-isopropyl-1,6-dimethylheptalene-4,5-dicarboxylate (40) 
and Dimethyl 3-Ethyl-7-isopropyl-5,10-dimethylheptalene-1,2-dicarboxylate (40’). 
Sulfone (P*)/(M*)-23 (0.200 g, 0.392 mmol) was subjected to the standard procedure. 
Chromatography gave a 3 : 1 mixture of 40 an 40’ as orange colored oil (0.080 g, 
55%).  
 
Data of the 3 : 2 mixture of 40/40’: IR (film): 1732s (C=O, ester). 1H-NMR (300 
MHz, CDCl3, 300 K): 6.48 br. s, H–C(4) of 40’); 6.40 – 6.32 (superimp. signals of H–
C(8,9) of 40’ and H–C(8) of 40); 6.15 (d-like, H–C(7) of 40); 6.02 (d-like, 4J(2,Me–
C(1)) = 1.4, H–C(2) of 40); 5.84 (s, H–C(10) of 40); 5.75 (br. s, H–C(6) of 40’); 3.86 
and 3.64 (2s, MeOOC–C(5) and MeOOC–C(4) of 40’); 3.67 and 3.61 (2s, MeOOC–
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C(5) and MeOOC–C(4) of 40); 2.70 – 2.40 (superimp. signals of MeCH2–C(3), 
Me2CH–C(9), and Me2CH–C(7) of 40 and 40’); 2.02 – 1.99 (superimp. signals of 
Me–C(1,6) of 40 and Me–C(5) of 40’); 1.66 (s, Me–C(10) of 40’); 1.15 – 1.05 
(superimp. signals of MeCH2–C(3), Me2CH–C(9), and Me2CH–C(7) of 40 and 40’). 
EI-MS: 368 (51, M+), 353 (47, [M – Me]+), 309 (15, [M – COOMe]+), 256 (100, [M – 
EtC≡CCOOMe]+).  
 
3.1.6. Dimethyl (M*,3E,4S*)-3-Ethylidene-9-isopropyl-1,4,6-trimethylheptalene-4,5-
dicarboxylate ((M*)-42). Sulfone (P*)-41 (0.100 g, 0.191 mmol) was reacted under 
the standard conditions with MeONa/MeOH. TLC on silica gel (hexane/Et2O 4 : 1) 
gave (M*)-42 as orange colored oil (0.015 g, 21%). 
 
Data of (M*)-42: IR (film): 1732s (C=O, ester). 1H-NMR (300 MHz, CDCl3, 300 K): 
6.55 (br. s, H–C(2)); 6.33 (s, H–C(10)); 6.26 (d, 3J(8,7) = 6.9, H–C(8)); 6.11 (dd-like, 
3J(7,8) = 6.8, 4J(7,Me–C(6)) = 1.4, H–C(7)); 5.69 (q, 3J(1’,Me–C(1’)) = 7.0, H–
C(1’)); 3.74 (s, MeOOC–C(5)); 3.49 (s, MeOOC–C(4)); 2.51 (sept, Me2CH–C(9)); 
2.01 (s, Me–C(1)); 1.887 (d, 3J(Me–C(1’),1’) = 6.8, Me–C(1’)); 1.875 (s, Me–C(6)); 
1.49 (s, Me–C(4)); 1.17 and 1.16 (2d, Jvic = 6.9 and 6.8, Me2CH–C(9)). 13C-NMR (150 
MHz, CDCl3, 300 K): 176.19 (MeOOC–C(4)); 168.79 (MeOOC–C(5)); 146.79 
(C(9)); 141.74 (C(C5a)); 135.82 (C(3)); 133.31 (C(10a)); 129.97 (C(1)); 129.31 
(C(5)); 128.89 (C(6)); 128.31 (C(10)); 127.00 (C(2)); 124.96 (C(1’)); 124.61 (C(8)); 
124.59 (C(7)); 52.57 (MeOOC–C(5)); 51.86 (C(4)); 51.67 (MeOOC–C(4)); 26.12 
(Me–C(1)); 23.68 and 22.80 (Me2CH–C(9)); 22.92 (Me–C(6)); 21.56 (Me–C(4)); 
14.02 (Me–C(1’)). CI-MS: 400.5 (73, [M + NH4]+), 385.5 (100, [M + 1]+), 351.4 (25, 
[(M + 1) – MeOH]+), 279.3 (8, [(M + 1) – (2 MeOH + C3H4)]+). 
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3.1.7. Dimethyl 2-Ethyl-9-isopropyl-1,6-dimethylheptalene-4,5-dicarboxylate (45). 
The furan-1-one (P*)-27 (0.050 g, 0.098 mmol) was reacted for 3 h under the 
standard conditions. Yield of 45 after chromatography (silica gel, hexane/Et2O 2 : 1) 
and crystallization from CHCl3: 0.027 g (81%). No traces of 45’ were found. 
 
Data of 45: Orange crystals, m.p. 142.2 – 143.1°. Rf (hexane/AcOEt 1 : 1) 0.60. 
UV/VIS (cyclohexane): max. 323 (sh, 3.13; long tailing up to 400), 283 (3.80), 253 
(3.91), 212 (4.06); min. 274 (3.80), 241.5 (3.89). IR (ATR): 1714 (C=O, ester). 1H-
NMR (600 MHz, CDCl3, 300 K; CHCl3 at 7.264): 7.527 (s, H–C(2)); 6.254 (d, 3J(8,7) 
= 6.5, H–C(8)); 6.152 (d, 3J(7,8) = 6.5, H–C(7)); 5.787 (s, H–C(10)); 3.705 (s, 
MeOOC–C(5)); 3.697 (s, MeOOC–C(4)); 2.476 (sept, Me2CH–C(9)); 2.324 (symm. 8 
line signal, Jgem = 14.8, Jvic ≈ 7.4, MeCH2–C(2)); 1.993 (s, Me–C(6)); 1.985 (s, Me–
C(1)); 1.107 (t, Jvic = 7.6, MeCH2–C(2)); 1.081 and 1.041 (2d, Jvic = 6.9 and 6.8, 
Me2CH–C(9)). 13C-NMR (150 MHz, CDCl3, 300 K; CDCl3 at 77.23): 167.99 
MeOOC–C(5)); 167.91 (MeOOC–C(4)); 148.78 (C(9)); 144.25 (C(3)); 138.19 (C(2)); 
137.10 (C(1)); 133.61 (C(10a)); 130.90 (C(5)); 128.50 (C(6)); 126.88 (C(7)); 125.35 
(C(10)); 124.70 (C(8)); 121.99 (C(4)); 52.23 (MeOOC–C(4)); 52.13 (MeOOC–C(5)); 
35.92 (Me2CH–C(9)); 26.71 (MeCH2–C(2)); 23.32 and 22.72 (Me2CH–C(9); corr. 
with 1.107 and 1.080, resp.); 22.41 (Me–C(6)); 21.78 (Me–C(1)); 13.69 (MeCH2–
C(2)). 
The structural parameters of 45 were determined by an X-ray crytal-structure analysis 
(cf. Table 7).   
 
3.1.8. Dimethyl 2-Ethyl-6,8,10-trimethylheptalene-4,5-dicarboxylate (46) and 
Dimethyl 4-Ethyl-6,8,10-trimethylheptalene-1,2-dicarboxylate (46’). Furan-1-one 
(P*)-30 (0.100 g, 0.207 mmol) was reacted and worked up in analogy to 3.1.7. A 
  ’   49 
thermally equilibrated 3 : 1 mixture of 46 and 46’ was obtained as brownish oil (0.046 
g, 65%). Rf (hexane/AcOEt 2 : 1) 0.70. 
 
Data of 46: 1H-NMR (600 MHz, CDCl3, 300 K, 74% of 46; CHCl3 at 7.260): 7.50 (s, 
H–C(3)); 6.13 (br. s, H–C(9)); 5.94 (br. s, H–C(7)); 5.79 (br. s, H–C(1)); 3.72 (s, 
MeOOC–C(4)); 3.69 (s, MeOOC–C(5)); 2.33 (symm. m, Jgem = 15.0, Jvic = 7.5, 
4J(MeCH2–C(2),1) = 1.3, MeCH2–C(2)); 2.01 (br. s, Me–C(8)); 1.97 (d, 4J(Me–
C(6),7) = 1.1, Me–C(6)); 1.73 (s, Me–C(10)); 1.16 (t, Jvic = 7.5, MeCH2–C(2)). 13C-
NMR (150 MHz, CDCl3, 300 K, 74% of 46; CDCl3 at 77.00): 167.96 (MeOOC–
C(4)); 167.53 (MeOOC–C(5)); 148.43 (C(5a)); 143.70 (C(2)); 142.55 (C(3)); 139.46 
(C(8)); 132.98 (C(4)); 132.05 (C(10)); 130.24 (C(9)); 129.90 (C(6)); 129.80 (C(1)); 
129.20 (C(7)); 122.87 (C(5)); 122.54 (C(10a)); 52.12 (MeOOC–C(4)); 51.87 
(MeOOC–C(5)); 29.06 (MeCH2–C(2)); 24.91 (Me–C(8)); 23.31 (Me–C(6)); 17.84 
(Me–C(10)); 14.01 (MeCH2–C(2)). 
 
Data of 46’: 1H-NMR (600 MHz, CDCl3, 300 K, 24% of 46’; CHCl3 at 7.260): 6.26 
(q-like, 4J(3,MeCH2–C(4)) ≈ 4J(3,5) = 1.1, H–C(3)); 6.09 (br. s, H–C(9)); 5.91 (quint-
like, H–C(7)); 5.72 (d, 4J(5,3) = 1.1, H–C(5)); 3.83 (s, MeOOC–C(2)); 3.70 (s, 
MeOOC–C(1)); 2.30 (symm. m, Jgem = 14.0, Jvic = 7.4, 4J(MeCH2–C(4),3) ≈ 0.7, 
MeCH2–C(4)); 2.11 (d, 4J(Me–C(6)),7) = 1.1, Me–C(6)); 1.96 (d, 4J(Me–C(8),9) = 
1.1, Me–C(8)); 1.63 (s, Me–C(10)); 1.08 (t, Jvic = 7.5, MeCH2–C4)). 13C-NMR (150 
MHz, CDCl3, 300 K, 24% of 46’; CDCl3 at 77.00; assigned signals): 168.82 
(MeOOC–C(4)); 166.97 (MeOOC–C(5)); 151.53 (C(4)); 144.18 (C(5a)); 141.46 
(C(10)); 139.19 (C(8)); 134.79 (C(6)); 134.11 (C(1)); 131.29 (C(9)); 130.03 (C(7)); 
125.30 (C(5)); 124.58 (C(2)); 122.53 (C(10a)); 122.25 (C(3)). 
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3.1.9. Dimethyl 2-Ethyl-1,6,8,10-tetramethylheptalene-4,5-dicarboxylate (47) and 
Dimethyl 4-Ethyl-5,6,8,10-tetramethylheptalene-1,2-dicarboxylate (47’). Furan-1-one 
(P*)-31 (0.091 g, 0.203 mmol) was reacted in analogy to 3.1.7. All starting material 
had been consumed after 0.75 h. Chromatography (silica gel, hexane/AcOEt 3 : 1) 
gave in a first fraction a 1 : 9 mixture of 47 and 47’ as brownish oil (0.048 g, 67 %). 
In a second fraction, we found small amounts (ca. 5 mg, 5 %) of the corresponding 
anhydride of (P*)-31, (P*,5R*)-6,7,9,11-tetramethyl-5-((S*)-1-(phenylsulfonyl)-
ethyl)-4,5-dihydro- heptaleno[1,2-c]furan-1,3-dione ((P*)-48). On standing in CDCl3 
solution over two month at ambient temperature in the laboratory, the 1 : 9 mixture of 
47 and 47’ was nearly completely converted into 47 (residual amount of 47’ max. 8 
%). 
 
Data of 47 after isomerization: 1H-NMR (600 MHz, CDCl3; CDCl3 at 7.260): 7.56 (d-
like, 5J(3,Me–C(1)) ≈ 0.7, H–C(3)); 6.14 (br. s, H–C(9)); 6.01 (br. s, H–C(7)); 3.70 (s, 
MeOOC–C(4)); 3.69 (s, MeOOC–C(5)); 2.34 (symm. 10 line m, Jgem = 12.0, Jvic = 7.6, 
MeCH2–C(2)); 2.04 (d, 4J(Me–C(8),9) = 1.2, Me–C(8)); 1.96 (d, 4J(Me–C(6),7) = 1.2, 
Me–C(6)); 1.90 (d-like, 5J(Me–C(1),MeCH2–C(2)) ≈ 5J(Me–C(1),3) ≈ 0.7, Me–C(1)); 
1.70 (s, Me–C(10)); 1.11 (t, Jvic = 7.6, MeCH2–C(2)). 13C-NMR (150 MHz, CDCl3; 
CDCl3 at 77.00): 167.85 (MeOOC–C(4)); 167.75 (MeOOC–C(5)); 146.89 (C(5a)); 
143.36 (C(3)); 138.49 (C(2)); 138.47 (C(8)); 136.07 (C(1)); 130.31 (C(9)); 130.23 
(C(6)); 130.15 (C(4)); 129.45 (C(10)); 128.59 (C(7)); 127.49 (C(10a)); 121.36 (C(5)); 
52.01 (MeOOC–C(4)); 51.79 (MeOOC–C(5)); 25.86 (MeCH2–C(2)); 25.04 (Me–
C(6)); 19.81 (Me–C(1)); 18.20 (Me–C(10)); 13.68 (MeCH2–C(2)).  
 
Data of 47’: 1H-NMR (300 MHz, CDCl3; in the presence of ca. 10 % of 47; CHCl3 at 
7.260): 6.44 (s, H–C(3)); 6.05 (br. s, H–C(9)); 5.96 (br. s, H–C(7)); 3.82 (s, MeOOC–
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C(2)); 3.70 (s, MeOOC–C(1)); 2.42 (ddd, Jgem = 15.0, Jvic = 7.5, 4J(MeCHAHB–C(2),3) 
= 1.3, MeCHAHB–C(2)); 2.28 (ddd, Jgem = 15.0, Jvic = 7.4, 4J(MeCHAHB–C(2),3) = 0.8, 
MeCHAHB–C(2)); 2.04 (d, 4J(Me–C(6),7) = 1.2, Me–C(6)); 1.99 (d, 4J(Me–C(8),9) = 
1.1, Me–C(8)); 1.75 (s, Me–C(10)); 1.00 (t, Jvic = 7.4, MeCH2–C(4)). 13C-NMR (75 
MHz, CDCl3; CDCl3 at 77.00; assigned signals): 129.96 (C(9)); 128.85 (C(7)); 122.76 
(C(3)); 52.40 (MeOOC–C(4)); 52.21 (MeOOC–C(5)); 30.15 (MeCH2–C(4)); 24.97 
(Me–C(8)); 22.54 (Me–C(5)); 17.60 (Me–C(10)); 14.55 (Me–C(6)); 13.82 (MeCH2–
C(4)). 
 
Data of (P*)-48: 1H-NMR (300 MHz, CDCl3; CHCl3 at 7.260): 7.73 (Ho of PhSO2); 
7.64 (Hp of PhSO2); 7.52 (Hm of PhSO2); 6.20 (s, H–C(10)); 6.00 (s, H–C(8)); 3.65 
(sext-like, 3J(1’,Me–C(1’)) = 7.2, 3J(1’,5) = 9.5, H–C(1’)); 3.01 (dt, 3J(5,1’) = 9.5, 
3J(1’,HS) = 3.4, 3J(1’,HR) = 4.4, H–C(5)); 2.86 (dd, 2J(HS,HR) =14.7, 3J(HS,5) = 3.4, 
HS–C(4)); 2.79 (dd, 2J(HR,HS) = 14.7, 3J(HR,5) = 4.4, HR–C(4)); 2.11 (s, Me–C(9)); 
1.94 (s, Me–C(7)), 1.92 (s, Me–C(11)); 1.75 (s, Me–C(6)); 1.15 (d, 3J(Me–C(1’),1’) = 
7.2, Me–C(1’)). 
 
4. Crystal-Structure Determination of 4, 5, 10, 27, 30, 31, 41, 45, and 48 (Table 7 
and Figs. 2 – 6)20). – All measurements were conducted using graphite-
monochromated MoKα radiation (λ = 0.71073 Å). For 27, 30, 31, 41, and 45, a Nonius 
KappaCCD area detector diffractometer [18,19] and an Oxford Cryosystems 
Cryostream 700 cooler were employed, while data for the remaining compounds were 
                                                
20) CCDC-761780–761788 contain the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from The Cambridge Crystallo-
graphic Data Centre via www.ccdc.cam.ac.uk/data request/cif.  
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collected on a Rigaku AFC5R diffractometer [20] mounted on a 12kW rotating anode 
generator. The data collection and refinement parameters are given in Table 7, views 
of the molecules are shown in Figs. 2 – 6. The intensities were corrected for Lorentz 
and polarization effects, and an absorption correction based on the multi-scan method 
[21] was applied for 30 and 31.  Each structure was solved by direct methods using 
either SIR92 [22] or SHELXS97 [23], which revealed the positions of all non-H-
atoms. The non-H-atoms were refined anisotropically. All of the H-atoms were placed 
in geometrically calculated positions and refined using a riding model where each H-
atom was assigned a fixed isotropic displacement parameter with a value equal to 
1.2Ueq of its parent atom (1.5Ueq for the methyl groups). The refinement of each 
structure was carried out on F2 using full-matrix least-squares procedures, which 
minimised the function Σw(Fo2 – Fc2)2. A correction for secondary extinction was 
applied in the cases of 5, 27, 30, 31, 41, and 45. For 41 and 45, six and four 
reflections, respectively, whose intensities were considered to be extreme outliers, 
were omitted from the final refinement. 
Compound 4 crystallises in a non-centrosymmetric polar space group and refinement 
of the absolute structure parameter yielded a value of 0.47(9), which indicates that the 
crystals are inversion twins and that the compound is racemic. Compound 48 also 
crystallises in a non-centrosymmetric polar space group, but the absolute structure has 
not been determined and has been assigned arbitrarily. The structure of 27 has two 
symmetry-independent molecules in the asymmetric unit. In the structure of 45, one 
terminal Me group of the iPr group is disordered. Two positions were defined for this 
group and refinement of constrained site occupation factors yielded a value of 
0.850(6) for the major conformation. Similarity restraints were applied to the bond 
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lengths involving the disordered C-atoms and they were restrained to have similar 
atomic displacement parameters. 
Neutral atom scattering factors for non-hydrogen atoms were taken from  [24a], and 
the scattering factors for H-atoms were taken from [25]. Anomalous dispersion effects 
were included in Fc [26]; the values for f ' and f " were those of [24b]. The values of 
the mass attenuation coefficients are those of [24c]. All calculations were performed 
using the SHELXL97 program [23]. The crystallographic diagrams were drawn using 
ORTEPII [27]. 
 
Table 7. Crystallographic Data for Compounds 4, 5, 10, 27, 30, 31, 41, 45, and 48 
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Text to Figures 
 
Fig. 1. Stereoscopic view of the AM1 calculated structure of (P*,5S*)-8-
isopropyl-3,3-dimethoxy-6,11-dimethyl-5-((R*)-1-(phenylsulfonyl)ethyl)-
4,5-dihydroheptaleno[1,2-c]furan-1-one (27) with dotted van der Waals 
surfaces of O=C(1) and Me–C(11) 
 
 
Fig. 2. Stereoscopic view of the X-ray crystal structure of dimethyl 
(P*,3R*,4R*)-1-methyl-3-(phenylsulfonylmethyl)-3,4-dihydroheptalene-
4,5-dicarboxylate (4) (50% probability ellipsoids) 
 
Fig. 3. Stereoscopic view of the X-ray crystal structure of dimethyl 
(P*,3S*,4S*)-1,6-dimethyl-3-((phenylsulfonyl)methyl)-3,4-dihydro- 
heptalene-4,5-dicarboxylate (10) (50% probability ellipsoids) 
 
Fig. 4. Stereoscopic view of the X-ray crystal structure of dimethyl (P*, 
3S*,4S*)-9-isopropyl-1,4,6-trimethyl-3-((S*)-1-(phenylsulfonyl)ethyl)-
3,4-dihydroheptalene-4,5-dicarboxylate (41) (50% probability ellipsoids)     
 
Fig. 5. Stereoscopic view of the X-ray crystal structure of one of the two 
symmetry-independent molecules (P*,5S*)-8-isopropyl-3,3-dimethoxy-
5-((R*)-1-(phenylsulfonyl)ethyl)-4,5-dihydroheptaleno[1,2-c]furan-1-one 
(27) (50% probability ellipsoids) 
 
Fig. 6. Stereoscopic view of the X-ray crystal structure of (P*,5R*)-3,3-
dimethoxy-6,7,9,11-tetramethyl-5-((S*)-1-(phenylsulfonyl)ethyl)-4,5-
dihydroheptaleno[1,2-c]furan-1-one (31) (50% probability ellipsoids) 
 
Fig. 7. AM1 calculated, hypothetical dienolate structures resulting from re and 
si attack (a) and b), respectively) of methanide at C(5) of (P)-configured 
1-furanone 28 (see text) 
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Scheme 16 
 
 
 
(+)-sc-(P)(–)-sc-(P)
b) ! (C(2)–C(3)–C(4}–C(5)).
TS
"Hf°a) 68.59 71.57 67.19
! [°]b) –59.5 0 66.2
a) Kcal#mol–1.
(–)-sc-(M)(–)-sc-(P) TS
"Hf°a) 68.59 75.19 67.19
! [°]c) 224.2 178 129.0
c) ! (C(5)=C(5a)–C(10a)=C(10)).  
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  Scheme 17 
 
 
 
(+)-sc-(P,3S,4S)(–)-sc-(P,3S,4S) TS
!Hf°a) –116.74 –114.34 –118.44
" [°]b) –69.5 0 65.0
(–)-sc-(M,3S,4S)(–)-sc-(P,3S,4S) TS
!Hf°a) –116.74 –99.85 –117.30
" [°]c) 234.7 119.8180
b) " (C(2)–C(3)–C(4}–C(5)).
a) Kcal#mol–1.
c) " (C(5)=C(5a)–C(10a)=C(10)).  
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Scheme19a)
a) AM1 calculated ΔHf° and ΔHf‡ in Kcal⋅mol–1 for R = Me.
b) (+)-sc-(M*,5S*): –118.4.
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Table 1. Michael Addition Reaction of ((Phenylsulfonyl)methyl)lithiuma) and 
Dimethyl Heptalene-4,5-dicarboxylates  
 
EMe
EMe
R
+ PhSO2CH2Li
–78°
THF
EMe
EMe
R
CH2SO2Ph
 
 
Heptalene-4,5-dicarboxylate  Michael Adductsb) 
R                Nr. Nr.         Yield [%] 
–––––––––––––––––––––––––––––––––––––––––––– 
H  1  2 69 – 95  
1-Me 3  4 67 
6-Me 5  6 67 
8-Me 7  8 76 
1,6-Me2 9 10 62c) 
––––––––––––––––––––––––––––––––––––––––––––– 
a) 1.1 Mol-equiv. of methyl phenyl sulfone were beforehand 
 lithiated with BuLi at –10°. Larger quantities of the nucleo- 
 phile lead to increasing amounts of tricyclic bis-adducts [4].  
b) Structural assignment of the cis-configured adducts see later. 
c) Methyl 1,6-dimethyl-4-((phenylsulfonyl)acetyl)heptalene- 
 5-carboxylate was formed in minor amount (3 %).   
 
Table 2. Relevant Torsion Angles Θ [°] of Dimethyl Heptalen-4,5-dicarboxylates 
with Methyl Groups in peri-Positiona) 
 
R
OMe
O
OMe
O
1
6
10 2
 
 
Atom Array     3 [–73.6]b) 5 [–71.6]   48 [–72.6]  45 [–107.3] 
___________________________________________________________________ 
C(1)=C(2)–C(3)=C(4)    34.0  32.0 (30.3)   33.5 (33.8)   35.0 (35.4) 
C(5)=C(5a)–C(10a)–C(1)  55.0  57.2 (56.1)   53.9 (56.2)   61.6 (62.6) 
C(6)–C(5a)–C(10a)=C(10)  54.7  56.8 (57.8)   54.0 (59.6)   59.4 (62.0) 
C(3)=C(4)–C=O           –20.8  –9.0 (–13.0) –20.7 (–19.9)  –6.3 (–16.5) 
C(5a)=C(5)–C=O           –23.6          –59.6 (–47.7)  –23.8 (–32.8) –61.0 (–32.8) 
___________________________________________________________________ 
a) AM1 calculated values; in parentheses X-ray data (see also Exper. Part, Table 7); 
3 (1-Me), 5 (6-Me), 48 (10-Me), 45 (1,6-Me2, 2-Et, 9-iPr). 
b) In brackets AM1 calculated ΔHf° values (Kcal⋅mol–1). 
 
 
Table 3. Change of Θ (C(5a)=C(5)–C(4)=C(OMe)O–) [°] on Axial Michael Addition of 
Methanide at C(3) of Dimethyl Heptalene-4,5-dicarboxylatesa) 
 
        
EMe
EMe EMe
R1
R2
R1
R2EMe
H
R1
R2
Me
OMe
O–
H
Me
OMe
O–
(ax)(ax)
resi
Me–Me–
(R*)(S*)
axial (P*,3S*) axial (P*,3R*)  
 
R1 = R2 = H        149.5 [–119.1]    1b)       –175.2 [–123.8] 
R1 = Me, R2 = H       144.6 [–124.5]    3       –175.6 [–130.3] 
R1 = H, R2 = Me       144.9 [–124.6]    5           178.0 [–126.9] 
R1 = R2 = Me       146.0 [–130.3]    9           178.2 [–133.7] 
_______________________________ 
a) According to AM1 calculations (see also Table 2); in brackets ΔHf° value of the shown  
axial forms.  
b) For X-ray structure analysis of 1, see [15]. 
Table 4. ΔHf° Values (Kcal⋅mol–1) of the cis-Diastereoisomers of Dimethyl 3-Methyl 
-3,4-dihydroheptalene-4,5-dicarboxylatesa) 
 
E
R1
R2
(+)-sc-(P*,3R*,4R*)
Me
H
E
R1
R2
(–)-sc-(P*,3R*,4R*)
Me
H
E
R1
R2
(–)-sc-(P*,3S*,4S*)
H
Me
E
R1
R2
(+)-sc-(P*,3S*,4S*)
H
Me
E
H
E
H
E
H
E
H
 
R1,R2     Nr.b) 
H,H 1  –93.75    –88.98           –92.25           –92.61 
Me,H 3        –99.25    –95.93           –99.24           –99.45 
H,Me     5        –98.23    –93.81           –99.09               –95.70 
Me,Me    9      –103.91  –100.92         –105.05        –103.03 
____________________ 
a) The stereochemical descriptors (+)- and (–)-sc refer to the sign of the ring 
torsion angle Θ (C(2)–C(3)–C(4)–C(5)). 
b) Nr. of the corresponding dimethyl heptalene-4,5-dicarboxylate. 
Table 5. Dienolate Intermediates of the 1,6-Addition of Model Nucleophiles at C(5) 
of Heptaleno[1,2-c]furan-1-onesa)  
 
OO OMe
OMe
R1R3
O–O OMe
OMe
R1R3
O–O OMe
OMe
RR
1
R3 R
2
R2
R2
R2
R2
R2
R–R–
resi
R
(P) (+)-sc-(P*,5S*)(+)-sc-(P*,5R*)  
 
Substituents            ΔHf°    Nr.      ΔHf°                   ΔHf°  
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
R1= R3 = Me,         –145.7 (42.5)  25ʼ   –79.3      –146.3 (57.9) 
R2 = H; R =Me 
R1 = R3 = H,         –146.6 (45.8)  28    –80.5     –148.5 (52.2) 
R2 = Me; R = Me 
R1 = R2 = Me,        –151.7 (49.0)  29    –85.4     –152.2 (58.6) 
R3 = H; R = Me 
----------------------------------------------------------------------------------------------------------------- 
R1= R3 = Me,         –156.0 (47.7)  25ʼ      –154.3 (62.8) 
R2 = H; R = iPr 
R1 = R3 = H,         –157.1 (44.8)  28      –158.1 (56.3) 
R2 = Me; R = iPr 
R1 = R2 = Me,        –161.9 (48.3)  29      –160.2 (63.0) 
R3 = H; R = iPr 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a) ΔHf° in Kcal⋅mol–1; 25ʼ = 25 with Me–C(8) instead of iPr–C(8); in parentheses Θ 
(C(3a)=C(4)–C(5)–C(6)). 
Table 6. ΔHf° Data of Model 3,3-Dimethoxy-4,5-dihydroheptaleno[1,2-c]furan-1-onesa)  
 
OO OMe
OMe
R1R3
OO OMe
OMe
RR
1
R3 R
2
R2
R2
R2
R
(–)-sc-(P*,5S*)(+)-sc-(P*,5R*)
O–O OMe
OMe
R1R3 R
2
R2
R
(+)-sc-(P*,5R*)
OO OMe
OMe
R1R3 R
2
R2
R
(–)-sc-(P*,5R*)
O–O OMe
OMe
RR
1
R3 R
2
R2
(+)-sc-(P*,5S*)
OO OMe
OMe
RR
1
R3 R
2
R2
(+)-sc-(P*,5S*)
H+ H+
 
 
R1 = R3 = Me,        –106.40      –102.45               –107.77             –102.29 
R2 = H; R = Me 
R1 = R3 = H,        –107.19      –105.35               –109.74             –104.76 
R2 = Me; R = Me   (–116.73)     (–114.16)              (–119.17)            (–113.44) 
R1 = R2 = Me,        –112.56      –107.54               –113.74             –107.48 
R3 = H; R =Me       (–121.91)     (–115.94)              (–121.68)            (–114.65) 
–––––––––––––––––––––––––––––––––––––– 
a) Calculated with AM1; Kcal⋅mol–1. 
b) In parentheses values for R = iPr. 
 
 
 
 
 
Table 7.  Crystallographic Data for Compounds 4, 5, 10, 27, 30, 31, 41, 45, and 48 
 
 4 5 10 27 30 31 41 45 48 
Crystallised from EtOAc / hexane ether / hexane ether / hexane EtOAc / hexane EtOAc / hexane EtOAc tBuOMe CHCl3 ether / hexane 
Empirical formula C24H24O6S C17H16O4 C25H26O6S C29H34O6S C27H30O6S C28H32O6S C30H36O6S C23H28O4 C17H16O4 
Formula weight [g mol-1] 440.51 284.31 454.53 510.64 482.59 496.61 524.67 368.47 284.31 
Crystal colour, habit yellow-green, plate red, prism colourless, plate yellow, tablet yellow, prism yellow, prism yellow, plate yellow, prism yellow, prism 
Crystal dimensions [mm] 0.11 ´ 0.35 ´ 0.37 0.30 ´ 0.42 ´ 0.50 0.10 ´ 0.26 ´ 0.48 0.07 ´ 0.22 ´ 0.25 0.08 ´ 0.15 ´ 0.22 0.10 ´ 0.12 ´ 0.27 0.05 ´ 0.20 ´ 0.22 0.17 ´ 0.20 ´ 0.32 0.23 ´ 0.25 ´ 0.47 
Temperature [K] 173 (1) 173 (1) 173 (1) 160 (1) 160 (1) 160 (1) 160 (1) 160 (1) 173 (1) 
Crystal system orthorhombic monoclinic monoclinic monoclinic monoclinic monoclinic orthorhombic triclinic orthorhombic 
Space group P212121 P21/c P21/n P21/c  P21/n P21/c Pbca P
_
1 P212121 
Z 4 4 4 8 4 4 8 2 4 
Reflections for cell determination 25 25 24 11173 29761 82443 6712 4695 25 
2θ range for cell determination [°] 25 – 35 38 – 40 30 – 40 4 – 52 4 – 55 4 – 55 2 – 55 4 – 56 33 – 39 
Unit cell parameters a [Å] 12.494 (2) 13.660 (2) 11.698 (2) 22.5162 (3) 16.5768(3) 14.3221(4) 14.4103 (2) 10.2548(4) 8.718 (2) 
 b [Å] 20.394 (2) 8.538 (2) 8.159 (4) 9.7064 (1) 8.3852(2) 11.6968(3) 17.6883 (2) 10.5119(5) 21.400 (2) 
 c [Å] 8.542 (2) 13.402 (2) 24.539 (2) 26.0362 (3) 18.5972(4) 14.8916(4) 20.8422 (3) 10.7388(4) 7.816 (2) 
 α [°] 90 90 90 90 90 90 90 61.856(2) 90 
 β [°] 90 114.471 (8) 101.910 (8) 109.0997 (6) 101.721(1) 92.471(2) 90 89.446(2) 90 
 γ  [°] 90 90 90 90 90 90 90 86.063(2) 90 
 V [Å3] 2176.6 (6) 1422.6 (4) 2292 (1) 5377.0 (1) 2531.10(9) 2492.4(1) 5312.5 (1) 1017.99(8) 1458.3 (5) 
F(000) 928 600 960 2176 1024 1056 2240 396 600 
Dx [g cm-3] 1.344 1.327 1.317 1.261 1.266 1.323 1.312 1.202 1.295 
µ(Mo Kα) [mm-1] 0.187 0.0942 0.180 0.161 0.167 0.171 0.165 0.0808 0.0919 
Scan type ω/2θ ω/2θ ω  ω φ and ω φ and ω φ and ω φ and ω ω/2θ 
2θ(max) [°] 55 60 55 52 55 55 55 56 60 
Total reflections measured 5742 4566 5917 83621 60677 56776 76106 20553 2907 
Symmetry independent reflections 5010 4142 5273 10566 5771 5720 6093 4817 2794 
Rint 0.024 0.020 0.042 0.066 0.091 0.066 0.084 0.042 0.022 
Reflections with I > 2σ (I) 3943 2979 3502 7327 4020 4332 4154 3582 1996 
Reflections used in refinement 5010 4142 5480 10556 5771 5720 6087 4813 2794 
Parameters refined 283 194 293 664 314 324 343 263; 13 193 
R(F) [I > 2σ(I) reflections] 0.0438 0.0591 0.0480 0.0463 0.0462 0.0445 0.0451 0.0537 0.0511 
wR(F2) [all data] 0.1103 0.1770 0.1297 0.1226 0.1175 0.1133 0.1222 0.1451 0.1903 
Weighting parameters [a; b] a) 0.041; 0.6247 0.0532; 1.5245 0.048; 0.858 0.0604; 0.6815 0.0523; 0.9278 0.0482; 1.3039 0.0616; 0.9896 0.0648; 0.4016 0.1127; 0.2596 
Goodness of fit 1.032 1.115 1.013 1.031 1.021 1.032 1.043 1.026 1.050 
Secondary extinction coefficient - 0.016(2) - 0.0022(3) 0.0060(8) 0.0070(9) 0.0013(3) 0.023(5) - 
Final Δmax/σ 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
Δρ (max; min) [e Å-3] 0.41; -0.19 0.42; -0.46 0.30; -0.34 0.34; -0.43 0.25; -0.35 0.27; -0.30 0.25; -0.33 0.61; -0.39 0.43; -0.31 
a) w-1 = σ2(Fo2) + (aP)2 + bP where P = (Fo2 + 2Fc2)/3 
 
